PAGE 1 _________________________________________________________ NORTH CAROLINA COUNTY OF WAKE IN THE GENERAL COURT OF JUSTICE SUPERIOR COURT DIVISION 13-CVS-11032 ____________________________________________________ STATE OF NORTH CAROLINA ex rel. NORTH CAROLINA DEPARTMENT OF ENVIRONMENT AND NATURAL RESOURCES, ) ) ) ) Plaintiff, ) ) V. )DEPOSITION OF MEGAN ) MARIA DAVIES, M.D. SIERRA CLUB, WATERKEEPER ALLIANCE, ) NEUSE RIVERKEEPER FOUNDATION, ) WINYAH RIVERS FOUNDATION, ROANOKE ) RIVER BASIN ASSOCIATION, and CAPE ) FEAR RIVER WATCH, INC., ) ) Plaintiff-Intervenors, ) ) v. ) ) DUKE ENERGY CAROLINAS, LLC, ) ) Defendant. ) _________________________________________________________ and _________________________________________________________ NORTH CAROLINA COUNTY OF MECKLENBURG IN THE GENERAL COURT OF JUSTICE SUPERIOR COURT DIVISION 13-CVS-14661 _________________________________________________________ STATE OF NORTH CAROLINA ex rel. NORTH CAROLINA DEPARTMENT OF ENVIRONMENT AND NATURAL RESOURCES, Plaintiff, V. CATAWBA RIVERKEEPERS FOUNDATION, INC., APPALACHIAN VOICES, YADKIN RIVERKEEPER, MOUNTAINTRUE, DAN RIVER BASIN ASSOCIATION, ROANOKE ) ) ) ) ) ) ) ) ) ) ) ) PAGE 2 RIVER BASIN ASSOCIATION, SOUTHERN ALLIANCE FOR CLEAN ENERGY, and WATERKEEPER ALLIANCE, ) ) ) ) Plaintiff-Intervenors, ) ) v. ) ) DUKE ENERGY CAROLINAS, LLC, ) ) Defendant. ) _________________________________________________________ WEDNESDAY, MAY 4, 2016 _________________________________________________________ ROOM 148 NORTH CAROLINA DEPARTMENT OF JUSTICE 114 WEST EDENTON STREET RALEIGH, NORTH CAROLINA 8:56 A.M. _________________________________________________________ VOLUME 1 PAGES 1 THROUGH 184 _________________________________________________________ PAGE 3 A P P E A R A N C E S ON BEHALF OF THE PLAINTIFF: ROY A. COOPER, III ATTORNEY GENERAL FOR THE STATE OF NORTH CAROLINA BY: ANITA LeVEAUX, SPECIAL DEPUTY ATTORNEY GENERAL ENVIRONMENTAL DIVISION GERALD ROBBINS, SPECIAL DEPUTY ATTORNEY GENERAL PUBLIC SAFETY SECTION JOHN P. BARKLEY, ASSISTANT ATTORNEY GENERAL HEALTH AND PUBLIC ASSISTANCE SECTION NORTH CAROLINA DEPARTMENT OF JUSTICE POST OFFICE BOX 629 RALEIGH, NORTH CAROLINA 27602-0629 919/716-6500 DREW HARGROVE, NORTH CAROLINA QUALITY 217 WEST JONES RALEIGH, NORTH 919/707-8613 ASSISTANT GENERAL COUNSEL DEPARTMENT OF ENVIRONMENTAL STREET CAROLINA 27603 ON BEHALF OF THE PLAINTIFF-INTERVENORS: FRANK S. HOLLEMAN, III, SENIOR LITIGATOR MYRA BLAKE, STAFF ATTORNEY NICHOLAS S. TORREY, STAFF ATTORNEY LESLIE GRIFFITH, ASSOCIATE ATTORNEY SOUTHERN ENVIRONMENTAL LAW CENTER 601 WEST ROSEMARY STREET, SUITE 220 CHAPEL HILL, NORTH CAROLINA 27516-2356 919/967-1450 ON BEHALF OF THE DEFENDANT DUKE ENERGY: BRENT A. ROSSER, ESQUIRE HUNTON & WILLIAMS, LLP BANK OF AMERICA PLAZA 101 TRYON STREET, SUITE 3500 CHARLOTTE, NORTH CAROLINA 28280 704/378-4700 PAGE 4 A P P E A R A N C E S (CONTINUED) LAUREN LLAMAS SENIOR COUNSEL, OFFICE OF THE GENERAL COUNSEL DUKE ENERGY DEC45A 550 SOUTH TRYON STREET CHARLOTTE, NORTH CAROLINA 28202 980/373-3698 COURT REPORTER: MICHAEL B. CARTER PRECISION REPORTING & TRANSCRIBING, INC. POST OFFICE BOX 1659 SPRING HOPE, NORTH CAROLINA 27882 252/478-6968 FAX: 252/478-6984 CELL: 919/215-3501 PAGE 5 T A B L E O F WITNESS C O N T E N T S DIRECT REDIRECT MEGAN MARIA DAVIES, M.D. BY MR. HOLLEMAN BY MR. ROSSER 8-84 161-184 84-161 EXHIBITS NUMBER DESCRIPTION PAGE PLAINTIFF-INTERVENORS 283 CITY OF RALEIGH 2014 CONSUMER CONFIDENCE REPORT ANNUAL DRINKING WATER REPORT 76 284 JUNE 29, 2015 LETTER TO B75 FROM NCDENR RE: RESULTS OF WATER SUPPLY WELL SAMPLING AND HEALTH RISK EVALUATION 2520 LONG FERRY ROAD SALISBURY, NC 80 285 JUNE 4, 2015 LETTER TO B39 FROM NCDENR RE: RESULTS OF WATER SUPPLY WELL SAMPLING AND HEALTH RISK EVALUATION 470 LEONARD ROAD SALISBURY, NC 80 286 RISK EXPLANATION FREQUENTLY ASKED QUESTIONS (5 PAGES) 85 287 E-MAIL CHAIN DATED 7/28 15 FROM KELLY RIDDELL TO JIM JONES AND OLIVIA JAMES RE: URGENT MEDIA REQUEST (5 PAGES) 96 288 NCDEQ MEMORANDUM DATED NOVEMBER 4, 2015 101 FROM MATTHEW DOCKHAM, DIRECTOR OF LEGISLATIVE AFFAIRS TO THE ENVIRONMENTAL REVIEW COMMISSION AND THE JOINT LEGISLATIVE OVERSIGHT COMMITTEE ON HEALTH AND HUMAN SERVICES RE: INTERIM REPORT ON THE STUDY OF STANDARDS AND HEALTH SCREENING LEVELS FOR hexavalent CHROMIUM AND VANADIUM 289 EPA OFFICE OF WATER DOCUMENT DATED DECEMBER 2010 CHROMIUM-6 IN DRINKING WATER (3 PAGES) DEFENDANT 104 PAGE 6 EXHIBITS (CONT’D) DEFENDANT NUMBER DESCRIPTION PAGE 290 E-MAIL CHAIN DATED FEBRUARY 16, 2015 FROM MINA SHEHEE TO MEGAN DAVIES RE: FWD: CHROMIUM VI (2 PAGES) 291 NCDEQ MEMORANDUM DATED APRIL 1, 2016 112 FROM MOLLIE YOUNG, DIRECTOR OF LEGISLATIVE AFFAIRS TO THE ENVIRONMENTAL REVIEW COMMISSION AND THE JOINT LEGISLATIVE OVERSIGHT COMMITTEE ON HEALTH AND HUMAN SERVICES RE: FINAL REPORT ON THE STUDY OF STANDARDS AND HEALTH SCREENING LEVELS FOR HEXAVALENT CHROMIUM AND VANADIUM 292 NCDENR LETTER DATED 1/16/14 FROM DEXTER MATTHEWS TO MEGAN DAVIES RE: MEETING BETWEEN DHHS AND DENR AGREEING ON CONSISTENT STANDARDS AND CALCULATIONS FOR PRIVATE WELL OWNER HRE'S (2 PAGES) 114 293 ENVIRONMENTAL WORKING GROUP REPORT CHROMIUM-6 IN U.S. TAP WATER 122 294 WINSTON SALEM JOURNAL ARTICLE 3/19/16 WELL OWNERS IN DISBELIEF ABOUT STATE'S DECISION TO LIFT TAINTED WATER WARNING. (6 PAGES) 145 295 E-MAIL CHAIN DATED 8/21/15 FROM MINA SHEHEE TO MEGAN DAVIES RE: HEALTH STUDY (5 PAGES) 147 296 REPORT OF CANCER INCIDENCE RATES IN NORTH CAROLINA COUNTIES WITH COAL ASH STORAGE FACILITIES PREPARED BY THE NORTH CAROLINA CENTRAL CANCER REGISTRY DATED AUGUST 27, 2015 (6 PAGES) 155 107 PAGE 7 S T I P U L A T I O N S PRIOR TO EXAMINATION OF THE WITNESS, COUNSEL FOR THE PARTIES STIPULATED AND AGREED AS FOLLOWS: 1. OBJECTIONS TO QUESTIONS AND MOTIONS TO STRIKE ANSWERS NEED NOT BE MADE DURING THE TAKING OF THIS DEPOSITION, BUT MAY BE MADE FOR THE FIRST TIME DURING THE PROGRESS OF THE TRIAL OF THIS CASE OR ANY PRE-TRIAL HEARING HELD BEFORE THE JUDGE FOR THE PURPOSE OF RULING THEREON OR AT ANY OTHER HEARING OF SAID CASE AT WHICH SAID DEPOSITION MIGHT BE USED, EXCEPT AN OBJECTION AS TO THE FORM OF A QUESTION MUST BE MADE AT THE TIME SUCH QUESTION IS ASKED OR OBJECTION IS WAIVED AS TO THE FORM OF THE QUESTION; 2. THAT THE WITNESS DOES NOT WAIVE READING AND SIGNING OF THE TRANSCRIPT. MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 8 P R O C E E D I N G S 2 (WHEREUPON, 3 MEGAN MARIA DAVIES, M.D. 4 WAS CALLED AS A WITNESS, DULY SWORN, AND TESTIFIED AS 5 FOLLOWS:) 6 D I R E C T 7 BY MR. HOLLEMAN: 8 9 Q. E X A M I N A T I O N 8:56 A.M. Dr. Davies, we met a few minutes ago. My name is Frank Holleman, I am an attorney with the Southern 10 Environmental Law Center. And we represent conservation 11 groups who have intervened in this State Enforcement 12 Action, where we are seeking the clean up of coal ash 13 pollution around North Carolina. 14 deposition before? Have you ever been in a 15 A. I have not. 16 Q. I am sure you have been told this by your 17 attorneys, but just for the record, I am going to be 18 asking you a series of questions. 19 understand me or if you can't hear me, or if I get 20 confused, let me know and I will try to clarify the 21 question. 22 And if you don't Also, when you are answering questions from 23 me, you need to say "yes" or "no" for the court reporter, 24 because he gets frustrated by head shaking. 25 other thing I wanted to make sure you are aware of, we And the MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 9 1 are of course in a conference room here in a government 2 building in a -- perhaps a less formal setting. 3 testimony you are giving today is under oath. 4 as though you were in an official courtroom; do you 5 understand that? 6 A. I do understand that. 7 Q. Great. 8 But the And it is Well, first, could you state your full name for the record? 9 A. Megan Maria Davies. 10 Q. And Dr. Davies, I understand you are an 11 official of the North Carolina Department of Health and 12 Human Services, is that correct? 13 A. Yes. 14 Q. And what is your position? 15 A. I am the State Epidemiologist and Epidemiology 16 Section Chief. 17 Q. 18 And are you in a department or some sub-portion of HHS? 19 A. Yes. 20 Q. And what is that? 21 A. The Division of Public Health. 22 Q. And to whom do you report? 23 A. I report to Danny Staley, the Division 24 25 Director. Q. And is that a man or a woman? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 10 1 A. Man. 2 Q. And to whom does he report? 3 A. He reports to Dr. Randall Williams. 4 Q. And what is Dr. Randall Williams’ position? 5 A. He is the Health Director and the Deputy 6 Secretary for Health. 7 MR. ROSER: 8 speak up just a little bit. 9 here. I am sorry. One second. I can barely hear you over 10 THE WITNESS: All right, sorry. 11 MR. ROSSER: Thank you. 12 BY MR. HOLLEMAN: 13 Q. And sometimes I drop my voice, too --- 14 A. (Interposing) That is all right. 15 16 17 Just I will try --Q. --- so if it is a problem from me, you just let me know. 18 A. --- little more. 19 Q. And who reports to you, Dr. Davies? 20 A. Matt Kimmer, Evelyn Faust, Mina Shehee, Julie 21 22 My voice is --- Cassani and Brenda Horne. Q. Now, we are here today, among other things, to 23 ask you questions concerning the Health Screening Levels 24 for hexavalent chromium and vanadium. 25 aware of that, correct? I guess you are MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 11 1 A. Yes. 2 Q. Which of those people you just identified 3 played any role in setting the Health Screening Levels 4 for those two substances? 5 A. Mina Shehee. 6 Q. And the others did not? 7 A. No. 8 Q. Now, as I understand it, is it correct that 9 your agency has set a Health Screening Level for 10 hexavalent chromium in drinking water of 0.07 parts per 11 billion? 12 A. Yes. 13 Q. I believe -- and correct me if this is wrong, 14 but I believe that is based on a statutory criteria of a 15 one in a million cancer risk, is that correct? 16 MS. LeVEAUX: Objection. 17 MR. ROSSER: Object to form. 18 MR. ROBBINS: Objection. 19 MR. BARKLEY: Objection. 20 THE WITNESS: No, I was just trying to 21 think. 22 23 You can answer. BY MR. HOLLEMAN: Q. Well, tell me what criteria is that based on? 24 What does that represent, 0.07 parts per billion of 25 hexavalent chromium. What does that represent? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 12 1 A. That criterion is an Administrative Code. 2 Q. Yes, and what kind of criterion is that? I 3 mean, what is the substance of the criterion and what 4 does it mean? 5 6 7 A. It is a one in one million risk of -- increased risk of cancer. Q. Now, if it is -- if you have -- instead of .07 8 parts per billion of hexavalent chromium in your water, 9 you have 0.7, that is ten times as much hexavalent 10 chromium; is that correct? 11 MS. LeVEAUX: Objection. 12 MR. ROBBINS: Objection. 13 THE WITNESS: Yes. 14 BY MR. HOLLEMAN: 15 Q. And does that mean, then, that your drinking 16 that has 0.7 parts per billion of hexavalent chromium is 17 less safe than drinking water that has the Health 18 Screening Level of 0.07. 19 MS. LeVEAUX: Objection. 20 MR. ROBBINS: Objection. 21 MR. ROSSER: Object to the form. 22 THE WITNESS: It is associated with a risk 23 of one in a hundred thousand of cancer. 24 25 BY MR. HOLLEMAN: Q. So it would be riskier -- drinking the water MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 13 would be riskier if it has 0.7? 2 MS. LeVEAUX: Objection. 3 MR. ROSSER: Objection to form. 4 THE WITNESS: It is associated with a higher 5 risk. 6 BY MR. HOLLEMAN: 7 Q. Of cancer? 8 A. Of cancer. 9 Q. And what kind of cancers are we talking about 10 here for hexavalent chromium? 11 A. Stomach tumors for ingestion. 12 Q. What about liver cancer; is that one of the 13 issues for hexavalent chromium? 14 A. Not to my knowledge. 15 Q. It is not? 16 A. Not to my knowledge. 17 Q. And you said stomach tumors. 18 I mean, not to your knowledge? Is that sometimes referred to as stomach cancer? 19 A. Yes. 20 Q. And I believe you have been a practicing 21 physician, is that right? 22 A. Yes. 23 Q. What symptoms does someone have who has 24 stomach cancer? 25 A. I have never diagnosed someone with stomach MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 14 cancer, and I -- I would be speculating on the symptoms. 2 Q. Did you study that in medical school at all? 3 A. Yes. 4 Q. Okay. 5 From your studies in medical school, what are the symptoms of someone who has stomach cancer? 6 A. I guess what I am trying to say is I don't 7 remember everything I studied in medical school, and I 8 don't know for sure what the symptoms of stomach cancer 9 are. 10 Q. Are you telling me you don't remember that? I 11 mean, you don't have to know with absolute certainty, as 12 though you read it this morning. 13 based on your general medical knowledge what are the 14 symptoms of stomach cancer? 15 A. I am just asking you So, I guess the problem I am having in 16 answering this is just -- I -- I could tell you what I 17 think they are. 18 symptoms of stomach cancer specifically. 19 I am a little uncomfortable when I am giving official 20 testimony about what the symptoms of a disease are when I 21 am not certain. 22 Q. Can you tell me what you think they are? 23 A. Yes. 24 Q. Okay. 25 A. I think they would be weight loss, abdominal I don't remember ever reviewing the So as a doctor, MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 15 pain, possibly blood in the stool, fatigue. 2 Q. Would nausea be a symptom? 3 A. It could be. 4 Q. And do people normally survive stomach cancer? 5 MR. ROSSER: Object to the form. 6 MS. LeVEAUX: Objection. 7 MR. ROBBINS: Objection. 8 THE WITNESS: I don't know. 9 BY MR. HOLLEMAN: 10 Q. And what is the treatment for stomach cancer? 11 A. I don't know. 12 Q. Did you ever have a patient with liver cancer? 13 A. I don't think so. 14 Q. Do you know the symptoms of liver cancer? 15 A. I know some of them. 16 Q. And what are they? 17 A. Abdominal pain. They can also have loss of 18 appetite, nausea. 19 with bleeding disorders and liver malfunction. 20 21 Q. As it advances, you can have problems And what are the consequences of liver malfunction? 22 A. So severe liver malfunction results in hepatic 23 encephalopathy. 24 that the liver cannot transform for you to excrete 25 anymore. The brain is affected by the chemicals MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 16 So you can have a build up of ammonia that causes your brain to be confused? 3 A. Yes. 4 Q. And do people normally survive liver cancer? 5 A. I don't know the statistic on liver cancer 6 7 survival, but it has a -- generally has a poor prognosis. Q. Now, you all sent out "do not drink" letters 8 to people around some of the coal ash sites because of 9 the level of hexavalent chromium in their drinking water 10 wells, is that correct? 11 A. No. 12 Q. How is that not correct? 13 A. We didn't send them out on the -- all of the 14 15 materials were sent by DEQ. Q. But you were aware that DEQ was sending out 16 "do not drink" letters to people who lived around coal 17 ash sites because of the levels of hexavalent chromium in 18 their well drinking water? 19 MS. LeVEAUX: Objection. 20 MR. ROSSER: Object to the form. 21 BY MR. HOLLEMAN: 22 Q. Is that correct? 23 MR. ROSSER: Objection. 24 MS. LeVEAUX: Objection. 25 THE WITNESS: I was aware that DEQ was MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 17 1 sending out an HRE -- Health Risk Evaluation -- form that 2 had a recommendation not to use water for drinking or 3 cooking based on a level above 0.7 -- sorry, 0.07. 4 Q. Do you remember when that was sent out? 5 A. I think they started being sent out in March 6 of 2015. 7 Q. Of 2015? Now, later, your Department and DEQ 8 sent a letter to well owners who had received the "do not 9 drink" advisories rescinding the "do not drink" advisory 10 and telling them it was safe to drink their water, is 11 that correct? 12 A. Yes. 13 Q. And when did that go out? 14 A. I think it was October of 2016. 15 No, wait, what year are we in, 2016? 16 Q. We are in 2016. 17 A. Okay. 18 19 20 21 22 I mean, 2015. Sorry, October 2016 [sic]. Maybe September. Q. Let me show you what has previously been marked Exhibit 276. MR. ROSSER: Frank, do you have copies of that -- 276? 23 MR. HOLLEMAN: That is a past exhibit. 24 MR. ROSSER: So did you all bring extra 25 copies of the past exhibits? MEGAN MARIA DAVIES, M.D. 1 5/4/16 MR. HOLLEMAN: I did not. PAGE 18 This is the court 2 reporter’s exhibit. 3 the "do drink" letter. 4 MR. ROSSER: What is the date on that? 5 MR. HOLLEMAN: 276 and it is --- 6 THE WITNESS: March 11th, 2016. 7 Yes, I was thinking of a different letter. 8 9 This is a "do not drink " -- this is BY MR. HOLLEMAN: Q. So, now, just for the record, looking at 276 10 -- Exhibit 276, does that refresh your recollection that 11 the "do drink" letters went out in March of 2016? 12 A. Yes. 13 Q. Now, why -- let me back up for a minute. Has 14 the 0.07 Health Screening Level for hexavalent chromium 15 changed? 16 A. No. 17 Q. And did you all obtain different testing 18 results for the wells of people who received the "do 19 drink" letter? 20 A. No. 21 Q. So why was the "do drink" letter sent, given 22 you had previously -- or DEQ had previously sent these 23 notices to well owners that they should not drink their 24 water because of their hexavalent chromium level? 25 MR. ROSSER: Object to the form. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 19 1 MS. LeVEAUX: Objection. 2 MR. ROBBINS: Objection. 3 THE WITNESS: I believe it was for the 4 reasons stated in the letter. 5 BY MR. HOLLEMAN: 6 Q. And what do you believe those reasons are? 7 A. That they were updated after extensive study 8 of how other cities, states and Federal Government 9 managed the elements hexavalent chromium and vanadium in 10 drinking water. 11 Q. Did you participate in those studies? 12 A. To me, the word "studying" means a research 13 project. 14 Q. Yes. Well, I don't know what it means. 15 well, I know what it means in the English language. 16 letter says "extensive study." 17 that extensive study referred to in the letter? I -The Did you participate in 18 A. Yes. 19 Q. And what did you do? 20 A. Reviewed Federal Standards and documents 21 around those, reviewed levels that other states have for 22 groundwater or drinking water. 23 what I did. 24 meetings and --- 25 Q. And that is basically And I was briefed by my staff on their Did you conduct any study of how other cities MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 20 1 manage hexavalent chromium and vanadium in drinking 2 water? 3 A. No. 4 Q. Which members of your staff participated in 5 6 this study? A. So in -- in reviewing documentation -- that 7 was the essence of what the study is, reviewing 8 documentation and practices in other settings. 9 Shehee, Kennedy Holt, is his last name, who is a Health 10 Risk Evaluator --- 11 12 MR. ROSSER: I am sorry. I am still kind I am sorry. Kennedy Holt -- of struggling to hear you. 13 THE WITNESS: 14 and I am just hesitating on the last name. 15 know if Ken Rudo did, also. 16 Kennedy. 17 Q. 19 in this study? 20 A. 22 And I don't I am sure about Mina and BY MR. HOLLEMAN: 18 21 Dr. All right. Did anyone else at HHS participate I think Dr. Williams also reviewed information. Q. And did anyone else outside of HHS -- anyone 23 outside of HHS participate in the study or was it only 24 done in HHS? 25 A. It was done in discussion with DEQ. MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 21 Did DEQ do any of the study, or did you just discuss it with them? 3 A. DEQ shared their understanding of the same 4 documentation that we were reviewing. And DEQ provided a 5 formal report to the General Assembly regarding water 6 standards for these constituents. 7 Q. And who at DEQ did what you just described? 8 A. Tom Reeder, Jay Zimmerman, Evan -- Evan Kane? 9 I believe he is a geologist. 10 Q. 11 know of? 12 A. Are those all of the people at DEQ that you Those are the people we had technical 13 discussions. 14 some of the technical discussions. 15 Q. Secretary van der Vaart also engaged in Anyone else in government, other than the 16 people you have listed, to your knowledge -- was anyone 17 else in government, other than the people you have 18 listed, to your knowledge, participants in the study? 19 20 A. I am going to ask John a question, to clarify --- 21 MR. BARKLEY: You can't ask -- sorry. 22 THE WITNESS: I can't ask you a question? 23 am just --- 24 25 I MR. BARKLEY: it. You need to ask him to clarify MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 22 BY MR. HOLLEMAN: 2 Q. 3 me know. If you are not clear about the question, let 4 MR. BARKLEY: You can ask him. 5 THE WITNESS: I guess I keep stumbling on 6 what you mean by "study." 7 letter says, "after extensive study." 8 doesn't mean -- it just means after reviewing the 9 literature. 10 I know the language of the To me, that BY MR. HOLLEMAN: 11 Q. Well, who else participated in that? 12 A. In reviewing the literature? 13 Q. In what you mean -- what you interpret 14 15 16 17 18 "extensive study" to mean? A. I think -- those are the people I know of who participated in that. Q. And did anyone outside of government participate in the study, to your knowledge? 19 A. No. 20 Q. Now, did you agree with the decision to send 21 out this letter? 22 A. No. 23 Q. Okay. 24 A. I was concerned -- let's see. 25 And why did you not agree with it? wasn't what I recommended. The timing And I felt that water in MEGAN MARIA DAVIES, M.D. 1 2 3 5/4/16 PAGE 23 public water systems were safer. Q. In other words, that municipal public water systems were safer than the well water? 4 MS. LeVEAUX: Objection. 5 MR. ROBBINS: Objection. 6 THE WITNESS: In terms of the levels of 7 hexavalent chromium detectable, yes. 8 BY MR. HOLLEMAN: 9 Q. Yes. And who did you express that concern to? 10 A. Dr. Williams. 11 Q. And what was his response? 12 A. We had multiple discussions about that there 13 isn't a clear, one way to handle this, and that in the 14 absence of regulations that all water suppliers were 15 answerable to, that making a specific recommendation to 16 this subset of people was not something he felt 17 comfortable with. 18 19 Q. Did he give you any other reason why he wanted to send the letter out? 20 A. Yes. 21 Q. What was that? 22 A. There was -- there were reports of efforts in 23 the General Assembly to construct legislation that would 24 restrict the Division of Public Health's ability to work 25 in the area of wells, in general. And I need to say, I MEGAN MARIA DAVIES, M.D. 5/4/16 1 -- this is what was discussed in meetings around 2 (inaudible). 3 MR. ROSSER: PAGE 24 I am sorry, Dr. Shehee [sic] 4 -- or Dr. Davies, I still am struggling to hear you over 5 here. 6 MS. LeVEAUX: And I am, too. 7 THE WITNESS: I am sorry, I just -- I don't 8 know what to do about it. 9 thing. Maybe you can turn off the air But if I have to spend several hours at the top 10 of my voice, I am not going to do well in this. 11 I said was -- can somebody else -- what I said was that I 12 was in discussions that included Dr. Williams about a 13 concern that there was an -- I don't know the right noun 14 -- effort -- there was discussion in the General Assembly 15 about passing legislation to restrict the Division of 16 Public Health's ability to work in the area of well 17 water. 18 19 So what BY MR. HOLLEMAN: Q. So was Dr. Williams concerned that if you did 20 not send out a "do not drink" letter, that members of the 21 General Assembly might restrict the administrative 22 authority of the Department of Public Health? 23 MS. LeVEAUX: Objection. 24 MR. ROBBINS: Objection. 25 MR. ROSSER: Objection to form. MEGAN MARIA DAVIES, M.D. 1 2 THE WITNESS: I don't -- I don't know how BY MR. HOLLEMAN: Q. Did he express that concern? 5 MR. ROSSER: Same objection. 6 MR. ROBBINS: Objection. 7 THE WITNESS: Yes. 8 BY MR. HOLLEMAN: 9 10 Q. Now, did he give any other reason why the "do not [sic] drink" letters should go out? 11 MR. ROBBINS: 12 BY MR. HOLLEMAN: 13 14 15 PAGE 25 specific -- I can't speak to his specific concerns. 3 4 5/4/16 Q. "Do drink." "Do drink" letters should go out. The "do drink" letters, excuse me. A. He expressed a lot of concern about the stress 16 that the people who had received the recommendation not 17 to use water for drinking or cooking were experiencing as 18 a result, and that while there is risk in the well water, 19 there is countervailing risk in not using your well 20 water, and having to use either bottled water or some 21 other source. 22 Q. Well, what is the countervailing risk in using 23 other water sources that don't have as much hexavalent 24 chromium in them? 25 MR. ROSSER: Objection to form. MEGAN MARIA DAVIES, M.D. 5/4/16 1 MS. LeVEAUX: Objection. 2 MR. ROBBINS: Objection. 3 BY MR. HOLLEMAN: 4 5 6 Q. PAGE 26 What is the countervailing risk he was referring to? A. In our discussions, we both were concerned 7 that people were experiencing a high degree of stress in 8 their everyday lives, that they were -- they were 9 changing the practices of how they ate and how they did 10 sanitation. And those are pretty fundamental public 11 health issues. 12 Q. Did you know that was happening? 13 A. There were reports in the media. 14 Q. Did you ask any of the -- did you or others in 15 your department, or Dr. Williams ask people in the 16 community who had received the letters if they had made 17 any of those kind of changes? 18 19 20 A. I did not. I don't know -- I can't speak to Dr. Williams. Q. Now, did you express your objections to Dr. 21 Williams' decision to send out the "do drink" letter in 22 writing? 23 A. No. 24 Q. On e-mail? 25 A. No. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 27 1 Q. Only verbally, is that correct? 2 A. Yes. 3 Q. Did anyone else at HHS object to the "do 4 drink" letter being sent out? 5 A. Yes. 6 Q. Who else? 7 A. Mina Shehee. 8 am sure. 9 Q. 10 11 12 13 Let me think. Mina is the one I Do you know if anyone else expressed objection, other than Ms. Shehee and yourself? A. I don't know of anybody who expressed objection to sending this letter besides Mina and myself. Q. Do you know -- was there anyone else who 14 objected to telling the well owners that it was 15 acceptable to drink their water? 16 A. Not that I know of. 17 Q. Did Dr. Rudo express objections to this course 18 of action? 19 A. Not that I know of. 20 Q. Did anyone else express concern -- well, let 21 me back up. Did anyone else in HHS express concern about 22 either sending out this letter or about telling well 23 owners it was acceptable to drink the water? 24 A. Yes. 25 Q. Who else? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 28 1 A. Danny Staley. 2 Q. Danny Staley? 3 A. Yes. 4 Q. And what is his job? 5 A. He is the Director of the Division of Public 6 Health. 7 8 10 12 The Director of the Division THE WITNESS: Public Health. of --- 9 11 MR. ROSSER: BY MR. HOLLEMAN: Q. And he is the gentleman to whom you report, is that correct? 13 A. That is correct. 14 Q. And what were his objections or concerns? 15 A. Similar to mine, that we both felt it made 16 more sense to wait on source determination, because once 17 a source was determined, we would have a sense of if this 18 -- the hexavalent chromium was a contaminant versus 19 naturally occurring. 20 a contaminant, there might be ongoing contamination of 21 wells with the increase in levels. 22 wait until all the information was in and DEQ had made a 23 determination, and then communicate with the well owners 24 in that full context. 25 Q. That is relevant because if it were So we felt we should And when you communicated with the well owners MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 29 1 in that full context, did you -- were you in favor of 2 telling them it was all right to drink their water? 3 A. I was in favor of telling them what their risk 4 level of the water was, that it isn't regulated anywhere 5 in North Carolina, and what they could do to treat their 6 water or reduce their risk if they chose to pursue that. 7 8 Q. But you wouldn't have told them "it is safe to drink water with hexavalent chromium above .07" ? 9 MS. LeVEAUX: Objection. 10 MR. ROBBINS: Objection. 11 MR. ROSSER: Objection. 12 THE WITNESS: No, I would not have. 13 BY MR. HOLLEMAN: 14 Q. Now did you express your objection to this 15 letter and this course of action to anyone in government, 16 outside of HHS? 17 A. No. 18 Q. Were you or your staff ever asked by anyone to 19 raise the Health Screening Level for hexavalent chromium 20 above .07? 21 A. No. 22 Q. Now, did you ever meet with Duke Energy about 23 the hexavalent chromium and vanadium levels prior to this 24 letter going out? 25 A. Yes. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 30 1 Q. And when did you meet with them? 2 A. There were two meetings: one by phone sometime 3 between March and June, and one in person, which was in 4 June of 2015. 5 6 7 8 9 Q. '15? Well let's start with the first one -- the phone conference. A. called. Q. Who was on the conference call? The -- I can't remember what they are It -- like, the legislative liaisons for Duke. Lobbyist? 10 MR. ROSSER: Object to the form. 11 THE WITNESS: Yes. 12 BY MR. HOLLEMAN: 13 Q. And what were their names? 14 A. I don't remember. 15 Q. Were they men or women? 16 A. Women. 17 Q. More than one? 18 A. Two. 19 Q. Two. 20 A. A Duke Energy environmental policy person 21 And who else was on the call? whose last name is McIntyre, I think. 22 Q. McIntyre? And that was a man? 23 A. Yes. 24 Q. And who else from Duke? 25 A. There were some lawyers, but I don't know MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 31 their names. 2 Q. Were they men or women or both? 3 A. I remember men. 4 Q. And who was on the call from the government? 5 A. I was, Danny Staley, Mina Shehee, Chris Hoke. 6 Q. Who is Chris Hoke? 7 A. Chris Hoke is in the Division of Public 8 Health. 9 policy. I think his title is Policy -- something about 10 Q. Is he a man? 11 A. Yes. 12 Q. And who else from the government was on the A. I think -- I think that was it. 13 14 15 call? I am not -- I really don't remember. 16 Q. And why was the call held? 17 A. Duke Energy requested to speak with Public 18 19 20 21 Health about our recommendations. Q. And how did you learn of that request; who told you? A. Mr. Staley. 22 MR. ROSSER: I am sorry, Dr. Davies? 23 THE WITNESS: Mr. Staley. 24 MR. ROSSER: Thank you. 25 BY MR. HOLLEMAN: MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 32 So Mr. Staley was contacted by Duke Energy about the call, is that your understanding? 3 A. I believe so. 4 Q. Or was he contacted by somebody else in 5 government that Duke Energy wanted the call? 6 MS. LeVEAUX: Objection. 7 THE WITNESS: My memory is he said he was 8 contacted by the legislative representatives, or the 9 lobbyists for Duke. 10 BY MR. HOLLEMAN: 11 12 Q. And why did Duke want to meet and talk with A. They wanted to understand why we had made the you? 13 14 Health Risk Evaluation recommendations that we were 15 making. 16 17 18 Q. And what did you and the staff from HHS tell A. We reviewed our rationale for the approach we them? 19 were taking, which was that CAMA -- the Coal Ash 20 Management Act -- directed the use of the North Carolina 21 Administrative Code 2L Standards in reviewing the well 22 water tested under CAMA. 23 DEQ, which was then DENR, to do the Health Risk 24 Evaluations for those water samples, we used 2L 25 Standards, IMACs and levels calculated according to the And so when we were asked by MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 33 1 2L Rule to set the Health Screening Standard. 2 a standard, but a Health Screening Level. 3 why we used the levels we used. 4 It is not And that is Q. And what did the Duke Energy people say to 6 A. I don't really remember. 7 Q. Did they explain the point of why they wanted 5 8 you? a call with you all? 9 10 MR. ROSSER: Objection. THE WITNESS: In general, the questions 11 were, you know, "Why are we looking at hexavalent 12 chromium and vanadium when public water is not held to 13 that standard?" 14 BY MR. HOLLEMAN: 15 Q. And your answer was? 16 A. To review our rationale, which we --- 17 Q. As you stated earlier? 18 A. As I stated earlier. 19 Q. And what else did the Duke Energy people say? 20 A. I don't remember. 21 Q. Do you remember any other concerns they 22 raised? 23 A. No. 24 Q. How did the call end? 25 A. It just ended. MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 34 So there was no resolution and no request from Duke Energy? 3 A. I don't remember. 4 Q. So tell me about the meeting with Duke. 5 did that occur? 6 A. That was in June. 7 Q. Of 2015? 8 A. 2015. 9 Q. And where did that occur? 10 A. That occurred at DEQ, the Green Square 11 When Building, in a conference room. 12 Q. And who was at the meeting? 13 A. Harry Sideris. 14 Q. Who is from Duke Energy? 15 A. Who is from Duke Energy -- Mr. McIntyre, the 16 Policy -- the Environmental Policy person for Duke 17 Energy, and several lawyers whose names I do not recall. 18 Q. Do you remember if they were men or women? 19 A. I think they were all men. 20 Q. And who else was there from -- let's start 21 with HHS. Who was there from HHS? 22 A. Danny Staley and me. 23 Q. And who was there from DEQ? 24 A. Secretary van der Vaart, John Evans, Tom 25 Reeder. Actually, I think there might have been MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 35 1 communications people there. 2 review all of my notes, but there were a lot of meetings 3 and discussions over a year and a half. 4 this meeting, the communications person from DHHS was 5 there -- Kendra Gerlach, and then a communications person 6 from DEQ was there. 7 So, I am sorry, I didn't So I think at But I am not positive. Q. Was there anybody else from the government 9 A. No. 10 Q. Was there anybody else there at all, 8 there? 11 government or not government, beyond the people you have 12 listed? 13 A. Not that I can think of. 14 Q. Now, how did you learn about the meeting? 15 A. I don't remember. 16 17 18 19 Somebody in my chain of command said there was a meeting being organized. Q. Were you told or did you learn why the meeting was being held or who had requested it? A. That Duke Energy had requested it. They -- 20 there was a letter -- actually, yes. 21 was addressed to me and Tom Reeder from Mr. Sideris 22 requesting explanation of our levels. 23 24 25 Q. I think the letter And what was -- what did the people from Duke Energy say? A. The main concerns that they expressed in the MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 36 1 meeting were around the levels we were using for Health 2 Screening Levels for hexavalent chromium and vanadium, 3 the issuing of recommendations not to use the water to 4 drink or cook, and a specific concern about a vanadium 5 screening level that was used in a situation about a year 6 before that was higher -- it was 18 I believe, parts per 7 billion -- and wanting to know why that was used in that 8 circumstance, and .3 micrograms per liter was used for 9 the CAMA wells. 10 11 Q. Did one person at Duke -- was one person from Duke the primary spokesperson for the company? 12 MR. ROSSER: Object to form. 13 THE WITNESS: Mr. Sideris did most of the 14 talking. 15 16 17 18 BY MR. HOLLEMAN: Q. Now, did Mr. Sideris or anyone else at Duke ask you all to rescind the "do not drink" advisories? A. I don't remember. He said he didn't think 19 they were reasonable, but I don't remember if he 20 specifically asked us to do that. 21 Q. Why was Duke concerned about these levels? 22 MR. ROSSER: Object to form. 23 MS. LeVEAUX: Objection. 24 MR. ROBBINS: Objection. 25 BY MR. HOLLEMAN: MEGAN MARIA DAVIES, M.D. 1 Q. 5/4/16 Do you know? 2 MR. ROSSER: Objection. 3 THE WITNESS: No. 4 BY MR. HOLLEMAN: 5 Q. PAGE 37 Do you know why you all were meeting with 6 Duke, of all people or companies, relating to these 7 levels? 8 A. Because they requested a meeting. 9 Q. Now, do you know if any Duke company 10 facilities drink from well water that was tested in 11 connection with this CAMA project? 12 A. I don't know. 13 Q. Did that come up in the discussions with Mr. 14 Sideris, or on the conference call? 15 A. I don't remember it. 16 Q. Well, do you have any idea, if Duke isn't 17 drinking the water, why would they have a say on what the 18 contamination level is appropriate in other people's 19 drinking water? 20 MS. LeVEAUX: Objection. 21 MR. ROBBINS: Objection. 22 MR. ROSSER: Objection to form. 23 THE WITNESS: I don't know. 24 BY MR. HOLLEMAN: 25 Q. You referred to the vanadium level at one time MEGAN MARIA DAVIES, M.D. 1 perhaps being 18. 2 happened? 5/4/16 PAGE 38 When did that -- do you know when that 3 A. That was the Summer of 2014. 4 Q. And could you explain what happened? 5 A. It was before CAMA was passed, or written. 6 Some people in, I want to say, Gaston County -- but it 7 was in an area near somewhere around a coal ash pond had 8 their water tested by a private laboratory and had 9 elevated vanadium. And DEQ consulted with the 10 toxicologists in the Occupational and Environmental 11 Epidemiology Branch that Dr. Shehee directs on what 12 recommendation to give those well owners. 13 14 15 16 Q. And what is the relevance of the 18 level to this event? A. The relevance is it is different than the level -- oh, to that? 17 Q. Was it used? What happened? 18 A. To that? 19 Q. Right. 20 A. To that? 21 Q. Right. 22 A. Yes, it was used as the screening level. What happened? It 23 was calculated by the toxicologists in the Division of 24 Waste Management and Occupational and Environmental 25 Epidemiology Branch of the Division of Public Health, MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 39 1 based on existing literature as the Health Screening 2 Level. 3 4 Q. And I believe that there is a so-called IMAC, interim standard for vanadium, correct? 5 A. Yes. 6 Q. And it is 0.3 parts per billion, is that 8 A. Yes. 9 Q. And was that -- I believe that was established 7 10 right? in 2010, is that right? 11 A. I don't know. 12 Q. Was it in effect when the 2014 event occurred, 13 do you know? 14 A. Yes. 15 Q. So why did they not use the IMAC in that 16 17 situation? A. When I asked my staff about it, they explained 18 that DEQ was considering updating the IMAC, and -- based 19 on literature. 20 toxicologists in DEQ, calculated the level at that time 21 and used it. 22 Q. And so they, in partnership with the Now, for reviewing the wells around the coal 23 ash sites you all, as I understand, used the IMAC as the 24 Health Screening Level, is that correct? 25 A. Yes. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 40 1 Q. And that is 0.3? 2 A. Yes. 3 Q. Now, why are you using that instead of 18? 4 A. Because the 2L Standard or the 2L Rule was 5 referenced in CAMA, and so we understood that to be our 6 direction. 7 8 Q. Do you know if your staff has determined that use of 18 was a mistake? 9 10 MR. ROSSER: Object to form. THE WITNESS: I asked my staff to relook at 11 vanadium when this was brought to my attention. 12 toxicologists on my staff re-reviewed the literature and 13 calculated a lower level. 14 And the BY MR. HOLLEMAN: 15 Q. And was that lower level 0.3? 16 A. No. 17 Q. Do you know what it was? 18 A. It was 2.4 something. 19 Q. But in the end, following the statute, you 20 used 0.3, is that correct? 21 A. Yes. 22 Q. Now, when the 0. -- oh, let me ask you this. 23 During your conversations with Duke Energy, either on the 24 phone or in person, did anyone in those meetings raise 25 this possibility of the legislature changing the Public MEGAN MARIA DAVIES, M.D. 1 5/4/16 Health Section's authority over wells? 2 MR. ROSSER: Object to form. 3 MS. LeVEAUX: Objection. 4 MR. ROBBINS: Objection. 5 THE WITNESS: No. 6 BY MR. HOLLEMAN: 7 PAGE 41 Q. Now, after the meeting with Duke in June of 8 2015, did you have any other meetings or conversations or 9 e-mail communications with Duke? 10 A. I received a letter from Mr. Sideris 11 summarizing his understanding of the meeting, and I 12 responded with a letter making some clarifications. 13 14 Q. And have you received any other communications from Duke Energy? 15 A. No. 16 Q. Do you know if Dr. Williams has met with Duke 17 Energy? 18 A. No. 19 Q. You don't know? 20 A. I don't know. 21 Q. Do you know if anyone else at HHS has met with 22 or talked with Duke Energy, other than the one phone call 23 and the one meeting in which you participated? 24 A. Yes. 25 Q. And who was that? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 42 1 A. Secretary Brajer. 2 Q. And -- Secretary who? 3 A. Rick Brajer. 4 Q. And he is the Secretary of the Department, 6 A. Yes. 7 Q. And when did he meet with Duke? 8 A. Sometime -- sometime between when he came on 5 9 10 11 12 13 14 15 16 17 18 HHS? board as the Secretary, which I think was the Summer of 2015, and -- sometime between summer and fall. Q. And when did the meeting occur? When did the meeting with the Secretary and Duke occur? A. Like -- can you clarify? Are you asking the time of day or --Q. I mean, do you know more than between those two time periods? A. No, I -- I don't. I wasn't present. I wasn't invited, so I don't know the date. 19 Q. Do you know who else was at the meeting? 20 A. No. 21 Q. Do you know where the meeting occurred? 22 A. No. 23 Q. Do you know who from Duke attended? 24 A. No. 25 Q. And how did you learn of the meeting? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 43 1 A. Secretary Brajer mentioned it in a meeting. 2 Q. And what did he say about it? 3 A. That he had met with them and -- really, I 4 5 6 don't recall much more. Q. Did he say they had discussed the hexavalent chromium or vanadium issues? 7 A. I don't remember. 8 Q. Did he say if they discussed the well water 9 issue in general? 10 A. Yes. 11 Q. Did he say what Duke had said to him? 12 A. I don't remember. 13 Q. Do you remember if this was a dinner at the 14 Governor's Mansion where he met with Duke? 15 A. I don't know. 16 Q. Now, have you ever met with the Governor or 17 anyone from the Governor's staff concerning the issue of 18 the wells or well water around coal ash sites? 19 20 A. I have not met with the Governor. I have spoken by phone with staff. 21 Q. And which of his staff have you spoken with? 22 A. Josh Ellis, Communications Office. 23 Matt McKillip. 24 Q. And what is Matt's role? 25 A. I don't know his title in the office of the MEGAN MARIA DAVIES, M.D. 1 Governor. 2 3 Q. 5/4/16 PAGE 44 He was at DHHS as a policy advisor. Well, let's start with the first person. I think his name was Josh, is that right? 4 (Witness nods affirmatively.) 5 Q. And how many times did you talk with Josh? 6 A. I can't give you an exact number, but several Q. And what -- did you call him or did he call A. It was usually a conference call that got 7 times. 8 9 10 11 12 you? arranged that I was invited to. Q. 13 It included him, obviously? (Witness nods affirmatively.) 14 Q. You need to say "yes," for the record. 15 A. Yes. 16 Q. And of course it included you. 17 Who else was on the conference calls with Josh? 18 A. Kendra Gerlach. 19 Q. And who is he? 20 A. She is a Communications Director in the 21 Department of Health and Human Services. 22 Q. And who else? 23 A. There were several calls, so there were 24 different people at different times. 25 distinguish them all in my memory. And I can't Some of those calls MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 45 1 probably had -- some of those calls had Danny Staley also 2 on the call. 3 4 Over what time period did the calls take A. Several in early 2015. I think probably March, mostly, of 2015. 7 8 Q. place? 5 6 That is what I am sure of. Q. Did any of the calls deal with the "do drink" letter that was issued in March of 2016? 9 A. No. 10 Q. Did the calls deal with the "do not drink" 11 advisory that went out in -- around June of 2015? 12 A. Yes. 13 Q. And what was expressed to you by Josh at the 14 Governor's Office? 15 16 A. Concern over wording on the Health Risk Evaluation form. 17 Q. And which part of the wording? 18 A. The main issue was wanting to have wording on 19 there that reflected that Safe Drinking Water Act 20 Standards were not exceeded. 21 Q. Well, that -- that is true because there 22 aren't any for hexavalent chromium and vanadium, is that 23 right? 24 MR. ROSSER: Object to the form. 25 MR. ROBBINS: Objection. MEGAN MARIA DAVIES, M.D. 5/4/16 1 MS. LeVEAUX: Objection. 2 THE WITNESS: Yes. 3 BY MR. HOLLEMAN: 4 Q. PAGE 46 And, in fact, when the letter was sent out, 5 people were told in the letter that "your well water has 6 been determined to meet all the criteria of the Federal 7 Safe Drinking Water Act for Public Drinking water"; is 8 that correct? 9 A. Yes. 10 Q. But they were not told, however, there were no 11 Federal Standards for vanadium or hexavalent chromium? 12 MR. ROSSER: 13 BY MR. HOLLEMAN: 14 Q. Object to the form. That was not included in the letter, was it? 15 MR. ROSSER: Objection. 16 MR. BARKLEY: Objection. 17 MS. LeVEAUX: Objection. 18 MR. ROBBINS: Objection. 19 THE WITNESS: I think not. 20 BY MR. HOLLEMAN: 21 Q. And did you all -- or did someone at HHS -- or 22 at DEQ, rather -- did someone at DEQ, did they change the 23 wording of the letter in response to the concerns of the 24 Governor's Office? 25 MS. LeVEAUX: Objection. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 47 1 MR. ROBBINS: Objection. 2 MR. ROSSER: Same objection. 3 THE WITNESS: So I need to step back and add 4 something about the calls. 5 communications person from DEQ. 6 I think it was a man. 7 that language on the HRE. 8 Some of those calls had a And I don't remember -- And DEQ was advocating for having BY MR. HOLLEMAN: 9 Q. Did anybody suggest, "Well, we should tell 10 these people, too, there aren't any Federal Standards for 11 the two substances that is in their water"? 12 MR. ROSSER: Object to the form. 13 MS. LeVEAUX: Objection. 14 MR. ROBBINS: Objection. 15 THE WITNESS: Yes. 16 BY MR. HOLLEMAN: 17 Q. And who said that or suggested that? 18 A. I did. 19 Q. And what did the Governor's Office say about A. There was a lot of general conversation on 20 21 that? 22 these calls. 23 Office -- what Josh Ellis said. 24 25 Q. And I don't remember what the Governor's Did Josh Ellis object to having that information in the letter? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 48 1 A. I don't remember. 2 Q. Did DEQ -- the DEQ person object to having it 3 in the letter? 4 A. Yes. 5 Q. And why did they object to telling the people 6 that? 7 MS. LeVEAUX: Objection. 8 THE WITNESS: So, again, I just want to be 9 clear that there were a series of phone calls. And I 10 can't distinguish every single call and say specifically 11 who said exactly what, when. 12 several conversations. 13 circular conversations. 14 This is a memory that spans And they were very similar So the conversation with DEQ about especially 15 hexavalent chromium and the Safe Drinking Water Act 16 Standards included -- had as a component of it that 17 several of the folks at DEQ felt that the total chromium 18 standard should serve as the hexavalent chromium 19 standard. 20 why --- 21 22 And so that was part of the argument about BY MR. HOLLEMAN: Q. But why wouldn't they want to tell the people 23 who received this notice the full information? 24 tell you -- give a reason for that? 25 MR. ROBBINS: Objection. Did they MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 49 1 MS. LeVEAUX: Objection. 2 MR. ROSSER: Object to the form. 3 THE WITNESS: No. 4 BY MR. HOLLEMAN: 5 6 Q. During these calls, did anybody raise any concerns of Duke Energy in the calls? 7 A. No. 8 Q. Do you remember anything else that was 9 10 discussed about the "do not drink" advisories that went out? 11 A. No. 12 Q. Now, I believe you said you talked with 13 someone else in the Governor's Office, and his name 14 is --- 15 A. Matt McKillip. 16 Q. And when did you talk with him? 17 A. So most of the time when I talked with -- when 18 Matt McKillip was part of conversations, he was in DHHS. 19 More recently, he was on one short conference call prior 20 to DEQ giving an update to the environmental -- the Coal 21 Ash Committee at the General Assembly. 22 asked to give an update to that committee. 23 So DEQ had been And in preparation, we had a very short phone 24 call. And at that call, DEQ requested that I be present 25 to speak to the levels. So Matt was on that call. MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 50 And when he was on the call, was he at the Governor's Office at that time? 3 A. Yes. 4 Q. And what was his role in the call? 5 A. He didn't really say much. 6 Q. What did he say, or what was the content of 7 8 9 what he said? A. That he thought it would be good if DPH had spoke specifically to the levels in the update. 10 Q. And did he say why? 11 A. No. 12 Q. I believe you said -- do you have notes of 13 your conversations? 14 that you didn't review your notes. 15 16 17 A. You referred to notes earlier -What notes are those? I have very limited notes. And, yes, I have some limited notes. Q. Now, if I could draw your attention back to 18 Exhibit 276, do you know who this letter went to? 19 that is the "do drink" letter. 20 HHS know who it was mailed to? And And by that I mean, does 21 A. Yes. 22 Q. And so you all have a list of people? 23 A. Yes. 24 Q. Now, did it go to every well owner who had 25 received the "do not drink" advisory? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 51 1 A. No. 2 Q. And how did the agency distinguish between who 3 got the "do drink" letter and who didn't get the "do 4 drink" letter? 5 A. This letter went to people who had levels 6 above the Screening Level for hexavalent chromium or 7 vanadium or both. 8 9 10 Q. So everybody who had levels above for vanadium, hexavalent chromium or both, got the "do drink" letter? 11 A. No. 12 Q. Okay. 13 A. It was not sent to anyone who had those Who didn't get it? 14 levels, plus something else that exceeded the 2L 15 Standard. So if you also had --- 16 Q. (Interposing) 17 A. Elevated, yes, then we didn't send the letter. 18 Q. Why did you make that distinction? 19 A. The letter was specific to hexavalent chromium 20 21 22 Iron for example? and vanadium. Q. Well, who made that -- who made the decision to make that distinction on the letters? 23 A. I don't know. 24 Q. How did you learn about that distinction? 25 A. We had conversations with Dr. Williams and MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 52 1 with the Communications Office about who should receive 2 the letter. 3 evolved. 4 Q. 5 So I learned about it as the conversations You didn't make the decision to make that distinction, is that correct? 6 A. Yes, that is correct. 7 Q. And no one who reports to you made that 8 decision, is that right? 9 A. That is correct. 10 Q. So it would either be -- am I correct to say 11 it would either be Mr. Daily [sic] or Mr. Williams or 12 someone above them? 13 A. Probably. 14 Q. Who wrote the letter? 15 Oh, before we get to that, does that distinction make sense to you? 16 A. It does. 17 Q. Well, isn't -- hexavalent chromium and 18 vanadium are more serious health concerns than iron, 19 aren't they; is that true? 20 MR. ROSSER: Object to form. 21 MS. LeVEAUX: Objection. 22 MR. ROBBINS: Objection. 23 THE WITNESS: No. 24 BY MR. HOLLEMAN: 25 Q. Is that true in this context of these people? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 53 1 MR. ROSSER: Same objection. 2 THE WITNESS: Yeah. 3 BY MR. HOLLEMAN: 4 Q. Yes. So tell me how that distinction makes sense, 5 that we will send it to people who have hexavalent 6 chromium and vanadium exceedances, but if they also have 7 iron, we are not going to send it to them? 8 MS. LeVEAUX: Objection. 9 THE WITNESS: One of the concerns we always 10 have is the interaction of chemicals. 11 part of discussions, I was concerned that we not 12 inadvertently send a letter to a well owner who might 13 have an elevation of something like lead. 14 15 16 17 And so when I was BY MR. HOLLEMAN: Q. I understand something like lead, but what about something like iron? A. So I think the logistics of doing this the 18 approach was to send this letter out to the people who 19 had only vanadium and/or hexavalent chromium, and then we 20 examine the other wells. 21 Q. Have any of the wells who were excluded from 22 the first round of letters subsequently gotten "do drink" 23 letters? 24 A. No. 25 Q. So no more "do drink" letters have gone out, MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 54 is that correct, since the first round on March of 2016? 2 A. Yes. 3 Q. Now, who wrote it? 4 A. It was dictated by Dr. Williams. 5 Q. And who did he dictate it to? 6 A. Well, I was present, and Mina Shehee did the 7 8 9 typing. Q. Now, when he dictated it was anybody else present other than you three? 10 A. Danny Staley. 11 Q. And after he dictated it, was it sent for 12 review by anyone? 13 A. Yes, I think so. 14 Q. To whom? 15 A. I don't know. 16 Q. And tell me why you think that? 17 A. Because this isn't exactly what he dictated. 18 It is very close. So it obviously got reviewed. 19 Q. Somewhere? 20 A. Yes. It certainly was reviewed by our 21 Communications Office, because they review all letters 22 that go out. 23 24 25 Q. Do you know of anyone who approved it before it went out, other than Dr. Williams? A. Well, presumably Mr. Reeder, since he signed MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 55 it. 2 Q. Yes. Other than Mr. Reeder and Mr. Williams? 3 A. I don't know of anybody else. 4 Q. Now, the 0.07 limit for hexavalent chromium, 5 as you said, that was calculated or determined by your 6 staff and your section. 7 its own? Did DEQ also do a calculation of 8 MS. LeVEAUX: Objection. 9 THE WITNESS: DEQ did a calculation in 10 discussion with -- after discussion with my toxicologist 11 on my staff, and then sent that to the Occupational 12 Environmental and Epidemiology Branch toxicologist to 13 review and see if they agreed with it. 14 15 16 Q. And did they reach -- did DEQ reach the same conclusion as HHS, 0.07? A. It is the opposite of what you are saying. 17 The DEQ toxicologist did the calculation and sent it to 18 DPH toxicologist to review. 19 agreed. 20 Q. 21 correct? And the DPH toxicologist So both agencies agreed with the 0.07, is that 22 MR. ROSSER: Object to form. 23 THE WITNESS: Yes. 24 BY MR. HOLLEMAN: 25 Q. Now do you remember what changed in the "do MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 56 1 drink" letter between Dr. Williams’ dictation and this 2 final version? 3 A. No. 4 Q. If we could look at the first sentence, that 5 first sentence says "We have withdrawn the do not drink 6 usage recommendation because we have determined your 7 water is as safe to drink as water in most cities and 8 towns across the state and country." 9 sentence? Do you see that 10 A. Yes. 11 Q. Is that true? 12 A. I don't know. 13 Q. Tell me why you have doubts about the truth of 14 that sentence? 15 MR. ROBBINS: Objection. 16 MS. LeVEAUX: Objection. 17 MR. ROSSER: Objection to form. 18 THE WITNESS: I think that sentence is in 19 reference to hexavalent chromium and vanadium. 20 haven't reviewed the hexavalent chromium levels in most 21 cities and towns in North Carolina. 22 23 And I BY MR. HOLLEMAN: Q. Now, are you aware that some of the people who 24 had hexavalent chromium tested in their wells had levels 25 of 20 or more? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 57 1 A. Yes. 2 Q. Are you aware of any town in North Carolina 3 that has been found to have hexavalent chromium at the 4 level of 20 or greater in its public drinking water 5 supply for hexavalent chromium? 6 A. No. 7 Q. Do you know, did Dr. Williams survey all of 8 the cities and towns across the state to determine the 9 levels of hexavalent chromium in their drinking water? 10 A. I don't know. 11 Q. Are you aware of anyone at HHS surveying the 12 levels of hexavalent chromium in their drinking water -- 13 in the drinking water supplies of public drinking water 14 facilities across the state? 15 MS. LeVEAUX: Objection. 16 THE WITNESS: No, I am not aware. 17 BY MR. HOLLEMAN: 18 Q. So when he was dictating this letter, did you 19 or Dr. Shehee or Dr. Williams himself raise a concern 20 about making that statement in the absence of evidence 21 supporting it? 22 MR. ROSSER: Objection to form. 23 MS. LeVEAUX: Objection. 24 MR. ROBBINS: Objection to form. 25 THE WITNESS: I expressed a concern based on MEGAN MARIA DAVIES, M.D. 1 PAGE 58 levels I had seen for Charlotte and Raleigh. 2 3 5/4/16 BY MR. HOLLEMAN: Q. Which are very low, is that correct? 4 MR. ROSSER: Objection to the form. 5 THE WITNESS: They are, on average, lower 6 than those measured in the drinking -- in the wells under 7 -- in the drinking wells under the CAMA sampling. 8 9 BY MR. HOLLEMAN: Q. And so what did he say? What did Dr. Williams 10 say about that? 11 A. I don't remember what Dr. Williams said. 12 Q. Do you remember the general content of his 13 14 response? A. He expressed confidence in the information Mr. 15 Reeder had given him, and that Mr. Reeder had said 16 publically multiple times. 17 18 19 Q. And Mr. Reeder had said this multiple times? Is that what you said? A. I didn't quite hear the --- (Interposing) He had said that public water 20 supplies have levels as high or higher than those in the 21 drinking wells. 22 Q. 23 Mr. Reeder said that, according to Dr. Williams? 24 A. Yes. 25 Q. And so when Dr. Williams wrote this, he was MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 59 relying on what Mr. Reeder told him? 2 MR. ROSSER: Object to the form. 3 THE WITNESS: He referenced what Mr. Reeder 4 told him. 5 6 7 BY MR. HOLLEMAN: Q. To your knowledge, did he refer to anything else he was relying on, other than what Reeder said? 8 A. No. 9 Q. Now, I guess you know a lot of the wells that 10 got the "do not drink" advisory were around this facility 11 called Buck in Salisbury, is that right? 12 (Witness nods affirmatively.) 13 Q. You need to say "yes" for the --- 14 A. Yes. 15 Q. And the nearby drinking water supply for that 16 community would be Salisbury, correct -- would be the 17 public drinking water system? 18 A. I don't know. 19 Q. Well, you know Buck is in Salisbury, right? 20 A. Yes. 21 Q. Do you know, did Dr. Reeder -- I am sorry. 22 Did Mr. Reeder or did Dr. Williams look at the Salisbury 23 report before they made this statement in the first 24 sentence, and sent it to people who lived in Buck [sic]? 25 VOICE: Objection. MEGAN MARIA DAVIES, M.D. 5/4/16 1 THE WITNESS: 2 BY MR. HOLLEMAN: 3 Q. PAGE 60 I don't know. Let me show you -- this has previously been 4 marked in Dr. Shehee's deposition, so this is nothing 5 new --- 6 MS. LeVEAUX: Mr. Holleman, which Exhibit is 8 MR. HOLLEMAN: This is Exhibit 278. 9 MS. LeVEAUX: Thank you. 7 that? 10 11 BY MR. HOLLEMAN: Q. And if you look on the second page -- I am 12 going to show it to you -- it is a Drinking Water Supply 13 Report from the town of Salisbury. 14 that next to the bottom blue box, do you see the levels 15 there for hexavalent chromium? 16 And if you look at (Witness peruses document.) 17 A. Yes. 18 Q. And they are all under one, correct? 19 They are all less than one? 20 A. Yes. 21 Q. Now, would you think, when sending this letter 22 to people who live in Salisbury, that the relevant water 23 system for them to compare themselves to is the 24 neighboring drinking water system? 25 that statement? Would you agree with MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 61 1 A. Yes. 2 Q. So do you believe, to have been truthful to 3 the people who lived around Buck, they should have been 4 informed that, in fact, the level of hexavalent chromium 5 in their wells is several hundred or thousands times 6 higher than what is in the neighboring public water 7 supply? 8 MR. BARKLEY: Objection. 9 MS. LeVEAUX: Objection. 10 MR. ROBBINS: Objection. 11 MR. ROSSER: Object to the form. 12 THE WITNESS: I think it would have been 13 ideal to have sent communications that were more specific 14 to location. 15 16 BY MR. HOLLEMAN: Q. And do you think those communications should 17 have included specific information about the neighboring 18 drinking water supply? 19 A. Yes. 20 Q. Do you know if Dr. Williams, since he sent 21 this letter out, has actually checked to see if it is 22 true that the hexavalent chromium levels in the drinking 23 water in most cities and towns across North Carolina --- 24 A. (Interposing) I don’t know. 25 Q. --- are comparable to these in these wells? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 62 1 A. I don't know. 2 Q. The second sentence says, "It is appropriate 3 to return to drinking and using your water for cooking, 4 bathing and other household uses." 5 that sentence? 6 A. That is not how I would say it. 7 Q. What would you have said? 8 A. I would have said something about, while there 9 Do you agree with is an elevated risk for -- associated with -- I am sorry. 10 I always say things really technically. 11 my limitations in communication. 12 elevated -- I would say something along the lines of 13 while there is an elevated risk (see attached chart) 14 associated with levels of hexavalent chromium above .07, 15 you can make a choice about that risk and how you use 16 your water. 17 department to discuss further. 18 Q. That is one of While there is an And please consult your local health So you would not have told them it is 19 appropriate to return to drinking the water; you would 20 have given them information and let them make that 21 decision? 22 MS. LeVEAUX: Objection. 23 MR. ROBBINS: Objection. 24 THE WITNESS: Yes. 25 BY MR. HOLLEMAN: MEGAN MARIA DAVIES, M.D. 1 Q. 5/4/16 PAGE 63 Now, let me show you Exhibit 279. As you can 2 see, it previously was in Dr. Shehee's deposition. 3 is one of the "do not drink" advisories that was sent to 4 a family in Salisbury; do you see that? 5 (Witness peruses document.) 6 A. Yes. 7 Q. And if you turn back to the first page, 8 please, so I can reference this. 9 -- hexavalent chromium in his well is 21, is that Do you see the chromium 10 correct? 11 A. It is 21.8 micrograms per liter. 12 Q. All right. 13 That Now, that is a significant multiple of .07, would you agree? 14 A. Yes. 15 Q. And I am using what I call Seneca math -- that 16 is where I went to high school -- so just correct me if I 17 have got it wrong, but that is -- seven would be a 18 hundred times more than .07, is that correct? 19 A. Yes. 20 Q. And so 21 would be, like, 300 times, is that 22 A. Yes. 23 Q. Would you agree that this gentleman's well 21 24 25 right? water is less safe than the well water in Salisbury? MR. ROBBINS: Objection. MEGAN MARIA DAVIES, M.D. 5/4/16 1 MS. LeVEAUX: Objection. 2 MR. ROSSER: Object to form. 3 BY MR. HOLLEMAN: PAGE 64 4 Q. Than drinking water in the Salisbury well? 5 A. This well water has more hexavalent chromium 6 in it, and therefore a higher associated risk for the 7 adverse health effects of hexavalent chromium. 8 Q. Which is cancer, right? 9 A. Yes. 10 Q. And would you agree, therefore, the water in 11 this gentleman's well is not as safe as the drinking 12 water at the Salisbury Public Water System, which has 13 less than one parts per billion? 14 MS. LeVEAUX: Objection. 15 MR. ROBBINS: Objection. 16 MR. ROSSER: Object to form. 17 THE WITNESS: Based on the hexavalent 18 chromium level, yes. 19 20 21 BY MR. HOLLEMAN: Q. Now, would you regularly drink drinking water, yourself, that has 21 parts of hexavalent chromium? 22 A. No. 23 Q. Would you recommend that -- when you were once 24 a physician -- a personal physician, would you recommend 25 to a patient that a patient regularly drink drinking MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 65 1 water that has a hexavalent chromium level of 21 parts 2 per billion? 3 A. No. 4 Q. Would you recommend someone drink drinking 5 water regularly that has hexavalent chromium above .07, 6 the Health Screening Level? 7 A. That depends. 8 Q. Depends on what? 9 A. On what their options are. 10 Q. Let's assume they have the option to obtain 11 drinking water at less than .07 hexavalent chromium from 12 another source. 13 and not drink the water with above .07? 14 A. 15 favorable, yes. 16 Q. Would you recommend they use that water If all of the other parameters were also Now, would you recommend to a patient that 17 they regularly drink drinking water that has 10 parts per 18 billion of hexavalent chromium? 19 A. No. 20 Q. What about five parts? 21 A. No. 22 Q. One part? 23 24 25 (Pause.) A. So I wouldn't recommend they regularly drink water -- are you asking would I tell that person not to MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 66 1 drink their water, or are you asking would I recommend 2 that they drink that water? 3 4 Q. Well, let's start would you recommend they regularly drink water above -- at one part per billion? 5 MR. ROSSER: Object to form. 6 THE WITNESS: No. 7 BY MR. HOLLEMAN: 8 9 Q. Now, the standard .07, is that for vulnerable people or is that just for an adult? 10 A. It is an adult. 11 Q. Would you be more careful with a pregnant 13 A. Yes. 14 Q. Would you be more careful with children? 15 A. Yes. 16 Q. Would you be more careful with infants? 17 A. Yes. 18 Q. So you would be more concerned -- you would 12 woman? 19 look, perhaps, at a lower level for pregnant women or 20 small children, is that correct? 21 22 23 A. I would consult a toxicologist for the calculation, but, yes. Q. Before Dr. Williams sent out this letter, did 24 he determine whether any of these households had small 25 children or pregnant women in them? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 67 1 MR. ROBBINS: Objection. 2 THE WITNESS: Not that I know of. 3 BY MR. HOLLEMAN: 4 5 Q. What about if you had pre-existing illness, would you be more careful? 6 A. Depending on the illness, possibly. 7 Q. What kind of illnesses would you be more 8 careful with? 9 A. Gastrointestinal or renal. 10 Q. If you look at the second paragraph, he has 11 the sentence about "in an extensive study." 12 already discussed that, I think. 13 "Based on this review, as well as our own independent 14 assessments, we have now concluded the water out of your 15 well is as safe as a majority of the public water systems 16 in the country." 17 And we have But then it says, What was Dr. Williams' independent assessment, 18 apart from what Mr. Reeder told him and the study you 19 described earlier? 20 A. I don't know. 21 Q. Now, this letter says, again, "All public 22 water systems are required to meet or exceed federal 23 standards for safe drinking water." 24 out, though, that there is no federal standard for either 25 vanadium or hexavalent chromium, is that right? It does not point This MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 68 letter doesn't say that? 2 MS. LeVEAUX: Objection. 3 MR. ROSSER: Objection to form. 4 MR. ROBBINS: Objection. 5 MR. BARKLEY: Objection. 6 (Witness peruses document.) 7 THE WITNESS: 8 BY MR. HOLLEMAN: 9 Q. It does not say that. When the letter was being drafted, did you or 10 Dr. Shehee suggest to Dr. Williams that he should put 11 that in this letter? 12 13 14 A. I did not. I don't remember if Dr. Shehee Q. The next sentence says -- not the next did. 15 sentence, the next paragraph says, "Now we have had time 16 to study and review more data." 17 or review of data, apart from what you have already 18 described? Do you know of any study 19 A. No. 20 Q. Now, the next to the last sentence says, "Our 21 mission at the Department of Health and Human Services 22 and the Department of Environmental Quality is to protect 23 the health and safety of all North Carolinians." 24 believe this letter supported that mission or was 25 consistent with that mission? Do you MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 69 1 MS. LeVEAUX: Objection. 2 MR. ROBBINS: Objection. 3 MR. ROSSER: Object to form. 4 THE WITNESS: No. 5 BY MR. HOLLEMAN: 6 Q. The final paragraph says, "During the next 7 several weeks, we will issue new forms that reflect this 8 updated usage recommendation." Did that happen? 9 A. No. 10 Q. And why did it not happen? 11 A. Dr. Shehee, Mr. Staley and I recommended 12 strongly against it. 13 Q. And why is that? 14 A. It didn't feel right. 15 Q. How didn't it feel right, or why didn't it 16 17 18 feel right? A. The Health Risk Evaluation was the same, and this letter already changed the recommendation. 19 Q. Could you explain that further? 20 A. It wasn't necessary. 21 Q. What kind of form was Dr. Williams and Mr. 22 Reeder contemplating? 23 MS. LeVEAUX: Objection. 24 THE WITNESS: Dr. Williams asked us to 25 revise the Health Risk Evaluation form that we had MEGAN MARIA DAVIES, M.D. 1 4 PAGE 70 originally used to reflect the new recommendations. 2 3 5/4/16 BY MR. HOLLEMAN: Q. So he was asking you to come up with a higher number than .07? 5 MS. LeVEAUX: Objection. 6 THE WITNESS: No. 7 BY MR. HOLLEMAN: 8 Q. What did he mean by "revise"? 9 A. To change the recommendation on the form. 10 Q. And the form -- is that what is attached to 11 12 13 14 Exhibit 279? A. That is the Well Water Information and Use Recommendations for Inorganic Chemical Contaminants. Q. And those of you who recommended against it 15 were not willing to issue a new form with those -- with 16 the changes Dr. Williams requested, is that right? 17 MS. LeVEAUX: Objection. 18 THE WITNESS: Yes. 19 BY MR. HOLLEMAN: 20 21 22 23 24 25 Q. Now, Dr. Rudo -- what is his role at your department? A. He is a toxicologist in the Occupational and Environmental Epidemiology Branch. Q. And what was his role with respect to determining the .07 Health Screening Level for hexavalent MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 71 chromium? 2 A. He worked with the toxicologist at DEQ, and 3 the other toxicologists in DHHS for -- not DHHS, but OEE, 4 the Occupational and Environmental Epidemiology, on what 5 Cancer Slope Factor to use in the equation in the 2L 6 Rule, and reviewed the results and agreed with them. 7 Q. Now correct me if I am wrong, but I believe 8 after it was determined, Dr. Rudo also appeared for the 9 Department at various public meetings to explain the 10 Health Screening Levels, is that correct? 11 A. That is correct. 12 Q. Now, is it correct that Dr. Rudo is now on 14 A. That is correct. 15 Q. And why is Dr. Rudo on leave? 13 leave? 16 MR. ROBBINS: Objection. 17 MR. BARKLEY: Objection. 18 THE WITNESS: He requested leave. 19 20 I -- I am not sure what is appropriate for me to say --MR. ROBBINS: I have to object and direct 21 her not to answer. 22 of the General Statutes, is confidential information. 23 Leave information, under Chapter 126 MR. HOLLEMAN: Well, let me ask this 24 question, and you can tell me if she can answer it. Does 25 his leave have anything to do with the change to the "do MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 72 drink" letter? 2 MR. ROBBINS: I would contend that anything 3 concerning his leave is confidential information under 4 Chapter 126. 5 6 MR. ROBBINS: And I would instruct her not to answer. 9 10 And you would instruct her not to answer? 7 8 MR. HOLLEMAN: BY MR. HOLLEMAN: Q. Let me do this: have you heard government 11 officials in North Carolina raise questions about whether 12 bottled water that is being provided to these residents 13 contains hexavalent chromium or vanadium? 14 A. Yes. 15 Q. Who have you heard raise those issues? 16 A. Tom Reeder, Bob Midgette, Jessica Godreau. 17 Q. And who is Bob Midgette? 18 A. He works in DEQ in the Public Water Supply -- 19 I think it is called the Public Water Supply Branch. 20 Q. And who is the third person? 21 A. Jessica Godreau. 22 Q. And who is she? 23 A. She directs the Public Water Supply Branch. 24 Q. Are you aware of any testing of bottled water 25 done by DEQ or HHS to determine the hexavalent chromium MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 73 levels in it? 2 A. No, I am not aware of any. 3 Q. Or vanadium levels? 4 A. No. 5 Q. Are you aware that the people at DEQ have any 6 factual basis to raise that issue? 7 MS. LeVEAUX: Objection. 8 MR. ROSSER: Objection. 9 MR. ROBBINS: Objection. 10 THE WITNESS: I don't know. 11 would have to ask them. 12 13 You really BY MR. HOLLEMAN: Q. But you don't know of any facts to indicate 14 there is hexavalent chromium or vanadium in the bottled 15 water that is being provided by Duke Energy to these 16 people? 17 MS. LeVEAUX: Objection. 18 THE WITNESS: I do not. 19 BY MR. HOLLEMAN: 20 Q. And, in fact, they could just go and fill the 21 bottles at the Salisbury Public Water System and know 22 they had low levels, couldn't they? 23 MR. ROSSER: Object to form. 24 MS. LeVEAUX: Objection. 25 MR. ROBBINS: Objection. MEGAN MARIA DAVIES, M.D. 1 2 THE WITNESS: PAGE 74 They would know they had the levels published. 3 4 5/4/16 BY MR. HOLLEMAN: Q. Are you familiar with -- and this is in an 5 exhibit that was in Ms. Shehee -- Dr. Shehee's 6 deposition, so I will show it to you. 7 EPA screening level for hexavalent chromium in tap water. 8 This is a report prepared by Duke Energy's expert. 9 Exhibit 277. 10 It refers to an It is I just wanted to ask you have you ever heard of what they are referring to there? 11 (Witness peruses document.) 12 A. Can you repeat the question? 13 Q. I am really just trying to find out what is 14 being referred to there when it talks about the EPA 15 screening level for hexavalent chromium in tap water. 16 you know what they are referring to? 17 A. Yes. 18 Q. What is that? 19 A. It is a Health Goal that EPA set for 20 hexavalent chromium of .3 micrograms -- no, I am sorry. 21 .03 micrograms -- .03 parts per billion. Do 22 Q. And that is approximately half of the Health 23 Screening Level that DEQ and HHS ultimately adopted, is 24 that correct? 25 A. Correct. MEGAN MARIA DAVIES, M.D. 1 Q. 5/4/16 PAGE 75 Now, when you review how state and federal 2 governments dealt with hexavalent chromium, did you 3 discover this standard? 4 A. Yes. 5 Q. And did you report it to Dr. Williams? 6 A. Yes. 7 Q. So when he refers in the "do drink" letter to 8 HHS's study of state and federal practices regarding 9 hexavalent chromium, that includes the fact that the EPA 10 has a Health Goal that is half of the Health Screening 11 Level for chromium --- 12 MS. LeVEAUX: Objection. 13 MR. ROBBINS: Objection. 14 MR. ROSSER: Objection. 15 BY MR. HOLLEMAN: 16 Q. --- for hexavalent chromium? 17 A. Yes. 18 Q. And when you were doing the study of -- survey 19 of state practices, did you come across the California 20 Public Health Goal? 21 A. Yes. 22 Q. And how much is it? 23 A. .02 micrograms per liter. 24 Q. Which is less than the EPA Goal, as well, is 25 that correct? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 76 1 A. Yes. 2 Q. And did you report that to Dr. Williams? 3 A. Yes. 4 Q. Now, have you heard any government officials 5 say publically that the water that people drink in 6 Raleigh has as much hexavalent chromium in it as in these 7 wells? 8 MR. ROSSER: Object to form. 9 THE WITNESS: Yes, I think so. 10 BY MR. HOLLEMAN: 11 Q. And who said that? 12 A. Tom Reeder. 13 Q. Okay. 14 Let me hand you this, if we can mark this as an Exhibit, please. 15 (PLAINTIFF-INTEVENOR EXHIBIT 283 16 WAS MARKED FOR IDENTIFICATION.) 17 And I am showing you what is Exhibit 283, 18 which, as you can see on the cover, is the City of 19 Raleigh 2014 Consumer Confidence Report. 20 the Raleigh Public Water System data in connection with 21 the study for the "do drink" letter? 22 Did you review (Witness peruses document.) 23 A. No, not for the "do drink" letter. 24 Q. All right. 25 A. Yes. Did you ever review it? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 77 1 Q. And when did you review it? 2 A. After Mr. Reeder and I presented to the 3 Legislative Committee. 4 Q. And what did you discover? 5 A. That most Raleigh city water hexavalent 6 chromium levels were, for the most part, mostly below 7 .07, and there were some that -- I looked at several 8 years. 9 there was no vanadium detected. 10 11 There were some that were a little above it. Q. And So did your review indicate to you that what Mr. Reeder said was not true? 12 MR. BARKLEY: Objection. 13 THE WITNESS: Yes. 14 BY MR. HOLLEMAN: 15 Q. Did you ever tell him that? 16 A. No, not Mr. Reeder. 17 Q. Did you tell Dr. Williams that? 18 A. Yes. 19 Q. And what did Dr. Williams say? 20 A. I don't remember. 21 Q. Did he communicate it to Mr. Reeder? 22 A. I don't know. 23 Q. Do you know if Mr. Reeder ever looked at the 24 25 actual data for the city of Raleigh? MS. LeVEAUX: Objection. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 78 1 VOICE: Objection. 2 THE WITNESS: I don't. 3 BY MR. HOLLEMAN: 4 Q. And did you look at the reports for other 5 major public water systems in the state of North 6 Carolina? 7 8 9 A. other. I looked at the reports for Charlotte and one And I think it was Fayetteville, but I am not --Q. And what did you learn when you looked at the 10 Charlotte one? 11 A. 12 The hexavalent chromium levels were mostly below our screening level; some were above it. 13 Q. But they were not large numbers, is that 14 correct? They were close to your screening levels? 15 A. Yes. 16 Q. I am sorry. This has been marked as an 17 exhibit before in Dr. Shehee's deposition as Exhibit 282. 18 I just want to see if you can tell us what that is, if 19 you know? 20 (Witness peruses document.) 21 A. I actually haven't seen this before. 22 Q. Okay. 23 All right, thank you. If you could just give it back to the court reporter. 24 (Pause.) 25 Could I see that again? It has got a second MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 79 page to it. 2 A. 3 minutes. 4 Yes. And I am going to need a break in a few MR. HOLLEMAN: Why don't we just take a break 6 MR. HOLLEMAN: OFF THE RECORD. 7 (A BRIEF RECESS WAS TAKEN.) 8 MR. HOLLEMAN: 9 BY MR. HOLLEMAN: 5 10 11 now. Q. ON THER RECORD. 10:43 A.M. 10:53 A.M. Have there been any -- are there any plans to change the vanadium Health Screening Level from the 0.3? 12 A. No. 13 Q. And just to make sure I ask this, because I 14 got caught up in my train of thought, at the June meeting 15 -- in-person meeting with Duke, did Duke make any 16 requests of HHS or DEQ? 17 A. 18 request. 19 Q. 20 I don't remember a request -- specific What about on the phone call that occurred before? 21 A. I don't remember. 22 Q. Are you aware, otherwise, of Duke making any 23 requests of HHS? 24 A. No. 25 Q. Have you been told not to talk to the press? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 80 1 A. No. 2 Q. Are you aware if anyone else at HHS has been 3 told not to talk to the press? 4 A. No. 5 Q. Do you know how many people got the "do drink" 6 letter? 7 A. I don't remember the number. 8 Q. But you all have that chart in HHS of who got 10 A. Yes. 11 Q. And are you all planning to send any more "do 9 12 it? drink" letters out? 13 A. No. 14 Q. Let's introduce this. 15 I want to show you two more examples of the "do not drink" advisory from June. 16 (PLAINTIFF-INTEVENOR EXHIBIT 284 17 WAS MARKED FOR IDENTIFICATION.) 18 Let me show you what has been marked as 284, 19 and ask you is that another example of one of the "do not 20 drink" advisories? 21 22 (Witness peruses document.) A. Yes. 23 (Witness peruses document.) 24 Okay. 25 (PLAINTIFF-INTEVENOR EXHIBIT 285 MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 81 WAS MARKED FOR IDENTIFICATION.) 2 Q. And I will show you what has been marked 3 Exhibit 285, and ask you if that is another example of 4 one of the "do not drink" advisories? 5 A. Yes. 6 Q. That Exhibit 282 which I showed you and you 7 were not familiar with -- as I understand it, you don't 8 know this document. 9 that says "Next Steps - OEEB recommends a drinking water It refers -- there is a second page 10 standard for Chrome 6 of 0.2 parts per billion. 11 represents a one in one hundred thousand lifetime cancer 12 risk." 13 in HHS or in your section? 14 15 16 17 This Are you familiar with any discussion about that A. Only in reference to the California Health Q. But you don't remember any talk about changing Goal. the .07 to .2 for a health screening level? 18 A. No. 19 Q. And when this says "a drinking water 20 standard," is that the same as a Health Screening Level, 21 or is that something different -- if you know? 22 know you have never seen this. 23 section, do those mean the same thing? 24 25 A. I mean, I But in your department or In DHHS, we have been in the habit of using those terms interchangeably. However, through this MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 82 1 experience in working with DEQ, we have been -- we have 2 learned that a standard is a level that is promulgated 3 through a very specific process. 4 consciously trying to use that term carefully to reflect 5 only those published standards. 6 Q. And so we are So would it be correct to say that, other than 7 the fact that California has -- now, California's Goal is 8 .02, is that correct? 9 A. That is correct. 10 MS. LeVEAUX: Objection. 11 THE WITNESS: That is correct. 12 BY MR. HOLLEMAN: 13 Q. Not 0.2? This refers to 0.2. 14 MS. LeVEAUX: Same objection. 15 THE WITNESS: Yes. 16 BY MR. HOLLEMAN: 17 18 Q. So you really just don't know what that is talking about, is that a correct statement? 19 A. I don't. 20 Q. Are you aware of anyone at DEQ or HHS who has 21 received anything of value from Duke Energy? 22 A. No. 23 Q. Going on a trip with them or play golf with 24 25 them or anything like that? A. No. MEGAN MARIA DAVIES, M.D. 1 Q. 5/4/16 PAGE 83 When you all did the analysis -- or when you 2 reviewed the analysis and reached the conclusion of 0.07 3 for hexavalent chromium, did you all communicate with the 4 United States -- that is, the federal Center for Disease 5 Control, CDC? 6 A. Yes. 7 Q. And what was that communication? 8 A. It was a consultation with CDC-ATSDR on -- to 9 10 11 12 verify that we were using the correct Cancer Slope Factor in the calculation. Q. And is the Cancer Slope Factor a critical part of the calculation? 13 A. Yes. 14 Q. And what was CDC's response? 15 A. They agreed that was the correct factor. 16 Q. Now, Dr. Davies, do you feel bad about HHS 17 having sent out those "do drink" letters with DEQ? 18 MR. ROBBINS: Objection. 19 MS. LeVEAUX: Objection. 20 MR. ROSSER: Objection to form. 21 THE WITNESS: I feel conflicted. 22 MR. HOLLEMAN: No further questions. 23 MR. ROSSER: I am sorry, I didn't get that THE WITNESS: Conflicted. 24 25 last part. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 84 1 MR. ROSSER: Thank you. 2 MR. HOLLEMAN: I don't have anything else. 3 MR. ROSSER: Can we take two minutes and we 4 switch sides? 5 MR. ROSSER: 6 (A BRIEF RECESS WAS TAKEN.) 7 MR. ROSSER: ON THE RECORD. 11:06 A.M. 8 D I R E C T E X A M I N A T I O N 11:06 A.M. 9 BY MR. ROSSER: 10 OFF THE RECORD. 11:03 A.M. Q. Dr. Davies, I am Brent Rosser. 12 A. Yes. 13 Q. I am with the law firm of Hunton & Williams, 11 We met earlier today. 14 on behalf of Duke Energy. 15 I have got some questions to ask you. 16 me about your areas of expertise -- your background, 17 including your educational background. 18 A. Thank you for your time today. I am a physician. First of all, tell I attended University of 19 North Carolina Chapel Hill School of Medicine, graduated 20 from UNC School of Medicine, and I did a residency in 21 Family Practice. 22 few years, I did a fellowship at the Centers for Disease 23 Control and Prevention in epidemiology, and I have 24 practiced as an epidemiologist since. 25 Q. After practicing family medicine for a And how long did you practice family medicine? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 85 1 A. Four years after residency. 2 Q. How long have you been an epidemiologist? 3 A. My fellowship was from 1998 to 2000, and I 4 5 6 have been practicing since then. Q. So 16 years. Do you have any expertise in setting standards under the Federal Safe Water Drinking Act? 7 A. No. 8 Q. What about do you have any expertise in 9 10 developing Maximum Contaminant Levels under the Federal Safe Water Drinking Act? 11 A. No. 12 Q. What about -- do you have any expertise in 13 setting National Primary Drinking Water Standards? 14 A. No. 15 Q. Do you have any expertise in setting State 16 17 Groundwater Standards? A. No. 18 (DEFENDANT EXHIBIT 286 WAS 19 MARKED FOR IDENTIFICATION.) 20 Q. 21 document here. 22 Exhibit 286. I am going to show you a Are you familiar with this document? (Witness peruses document.) 23 A. Yes, I am. 24 Q. All right. 25 A. This document is frequently asked questions What is this? MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 86 that is on the DEQ website. 2 Q. If you could just take a look at the first 3 page, at the bottom there it says, "according to the EPA, 4 MCL's" -- this is the last paragraph, second sentence -- 5 "MCL's ensure that drinking water poses neither a 6 short-term nor long-term health risk." 7 that statement? 8 A. Yes. 9 Q. And then it goes on to say, "When the EPA Do you agree with 10 looks at the health risks from drinking water 11 consumption, it calculates the ingested amount as though 12 individuals are drinking two liters of water per day for 13 a 70 year lifetime." Do you agree with that statement? 14 A. Yes. 15 Q. If you could move to the next page, under the 16 question, "What is a Health Risk Evaluation?" 17 that? Do you see 18 A. Yes. 19 Q. The first sentence there states that, "A 20 Health Risk Evaluation is a review by a toxicologist in 21 the North Carolina Department of Health and Human 22 Services to determine levels of risk associated with 23 drinking, bathing and other uses of the water." 24 see that? 25 A. Yes. Do you MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 87 1 Q. Do you agree with that statement? 2 A. Yes. 3 Q. Are you a toxicologist? 4 A. No. 5 Q. Do you believe you are qualified to issue a 6 Health Risk Evaluation? 7 A. No. 8 Q. The following sentence says that, "In making 9 this determination of risk, the department relies on 10 available scientific information, including but not 11 limited to, the same information that formed the basis of 12 federal drinking water standards and North Carolina 13 groundwater quality standards." Do you see that? 14 A. Yes. 15 Q. Do you agree with that? 16 A. Yes. 17 Q. Okay. 18 19 20 21 22 What qualifies as available scientific information? A. Generally published scientific papers and peer review journals. Q. What would qualify as unavailable scientific information? 23 A. I don't know. 24 Q. What criteria are applied by DHHS in 25 determining what qualifies as available scientific MEGAN MARIA DAVIES, M.D. 1 2 5/4/16 PAGE 88 information? A. I don't -- we don't determine what available 3 scientific information is. 4 determine -- we evaluate the quality of scientific 5 information based on methods and peer review. 6 7 8 9 Q. That is not our wording. And just in general, how is that sort of assessment done? A. In the context of the hexavalent chromium and vanadium, it is done by a toxicologist who has the 10 education and training to assess the quality of the 11 science. 12 Q. 13 We So that wouldn't be something you would undertake to do? 14 A. No. 15 Q. All right. It says here that "DHHS relies on 16 the same information that formed the basis of federal 17 drinking water standards." 18 has considered the same information that formed the basis 19 of federal drinking water standards? 20 A. How does DHHS know that it I can't answer that comprehensively, but in 21 general, the information that forms the basis of safe 22 drinking water standards is publicly available. 23 Q. So did DHHS consider that information as part 24 of its evaluation of Screening Levels for hexavalent 25 chromium and vanadium? MEGAN MARIA DAVIES, M.D. 1 2 A. 5/4/16 PAGE 89 I don't know -- I don't know exactly what the toxicologist reviewed. 3 Q. It also says that the Department considers the 4 same information that formed the basis for the North 5 Carolina groundwater quality standards. 6 question: how do you know that the department considered 7 the exact same information in considering the groundwater 8 quality standards? 9 10 A. Because they calculated it with the toxicologist in the Division of Waste Management. 11 12 Again, same Q. And so you know that they considered the exact same information? 13 A. No, I don't know that. 14 Q. So it says under the next question, the fourth 15 sentence, "At levels of cancer risk greater than 16 one-in-one million, for example, the department 17 recommends you do not drink the water." Do you see that? 18 A. Yes. 19 Q. What is the basis for that standard? 20 A. It is a standard of practice in Health Risk 21 Evaluation. 22 Q. And what is that standard of practice based 24 A. I don't know. 25 Q. These -- the standard screening levels are 23 upon? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 90 1 based upon, I think you testified earlier, that someone 2 would drink two liters a day for a lifetime, is that 3 right -- of water? 4 A. Yes, 70 years. 5 Q. 70 years? Do you know, just on a percentage 6 basis, how many people in their life time drink two 7 liters of water per day? 8 A. No. 9 Q. On a percentage basis, do you know how many 10 people drink two liters of water per day for 70 years? 11 A. No. 12 Q. Would you expect a typical person to drink two 13 liters of water a day for 70 years? 14 A. I don't know. 15 Q. The one in a million risk standard is higher 16 than the lifetime odds of death from getting struck by 17 lightning, a lethal dog bite, and a cataclysmic storm; 18 correct? 19 A. Yes. 20 Q. And, in fact, if my math is correct, the one 21 in a million standard is over seven times more likely -- 22 or I guess you are seven times more likely to get struck 23 by lightning and be killed then to develop cancer under 24 the one in a million standard. 25 A. Approximately, yes. Does that sound right? MEGAN MARIA DAVIES, M.D. 1 Q. 5/4/16 PAGE 91 And I looked this up on this National Safety 2 Council's Risk Perspective Scale. Apparently, there is a 3 one in 111,000 chance that a human will die by lethal 4 execution. 5 MR. HOLLEMAN: I have to object. 6 MS. LeVEAUX: Objection. 7 MR. HOLLEMAN: I do have to object to the 8 "walking encyclopedia" question. 9 BY MR. ROSSER: 10 Q. Assuming that is correct, would you agree 11 that, under that standard, that you are about nine times 12 more likely to be lethally executed than develop cancer 13 under the one in a million standard? 14 MR. HOLLEMAN: Same objection. 15 MR. ROBBINS: Objection. 16 THE WITNESS: Can you repeat the numbers 17 again? 18 19 BY MR. ROSSER: Q. Sure. One in 111,000. 20 MR. HOLLEMAN: Same objection. 21 MR. ROBBINS: Objection. 22 THE WITNESS: Approximately, yes. 23 BY MR. ROSSER: 24 25 Q. How many Health Risk Evaluations have you been involved in since your time at the Department? MEGAN MARIA DAVIES, M.D. 5/4/16 1 A. 2 exactly. 3 Q. Can you guess? 4 A. So what do you mean by “involved”? 5 Q. Well how do you define involved? 6 A. That I have been specifically consulted about 8 Q. That is fine. 9 A. I would say a handful. 10 Q. So less than 10? 11 A. Yes, probably. 12 Q. Less than five? 13 A. Probably more than five. 14 Q. How many of those have resulted in the 7 15 I don't know exactly. PAGE 92 So -- I don't know that. issuance of a "do not drink" letter? 16 A. I don't know. 17 Q. And so let me ask it this way: do you recall 18 ever in your role at DHHS sending a "do not drink" letter 19 before the letters we are talking about today? 20 21 A. sending "do not drink" letters before this. 22 23 24 25 I recall being briefed about and agreeing to Q. Before this? And what was the context of A. We review testing results from new wells that? routinely. And there have -- I can think of one time MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 93 when lead levels were elevated in some wells. 2 Q. These would have been private wells? 3 A. Yes. 4 Q. And private wells, under North Carolina law, 5 are required to be tested, is that right? 6 A. Yes. 7 Q. Are they required to be tested for --- 8 A. (Interposing) Let me correct that. 9 Q. Sure. 10 A. They are required to be tested when they are Q. When they are new, right. 11 new. 12 13 And so are they required to be tested for vanadium? 14 A. No. 15 Q. What about hexavalent chromium? 16 A. No. 17 Q. Do you know why? 18 A. No. 19 Q. What is the status of those "do not drink" 20 advisories? 21 A. I don't know. 22 Q. Did you follow up with the well owners on 24 A. My staff always does, but I don't. 25 Q. Any other instances where you have issued "do 23 that? MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 94 not drink" letters? 2 A. I personally don't issue them, so, no. 3 Q. Any other instances that you are aware of "do 4 5 not drink" letters being sent by the Department? A. In general, I am aware that when levels exceed 6 the screening levels being used for new wells, that a 7 Health Risk Evaluation recommending the water not be used 8 for drinking or cooking is issued. 9 10 Q. And is the form you send similar to what we have looked at today? 11 A. Yes, it is similar. 12 Q. Do you recommend to those well owners who 13 receive those "do not drink" letters to conduct 14 re-sampling? 15 A. In some cases. 16 Q. Why is that? 17 A. Usually it is related to -- for instance, lead 18 levels where we re-sample at different places and after 19 letting the water run at different times. 20 sometimes related to -- it is related to discerning where 21 the constituent is entering the water. 22 23 24 25 Q. So it is And so why is it important to do more than one sample in that case? A. In the case I am thinking of, it is because you are trying to determine if the lead is present in the MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 95 1 well itself, or whether it is in the pipes running from 2 the well to the person's house. 3 4 5 Q. And why, in some cases, do you not recommend that re-sampling be undertaken? A. So this is outside my area of expertise. And 6 the decisions are -- on this granular level, are made by 7 the toxicologists. 8 9 Q. Well, let me ask you based upon your role at the Department, why in some cases would the Department 10 issue a "do not drink" letter, but at the same time not 11 recommend that that well water be re-sampled? 12 A. When we issue the recommendation, we -- it 13 actually comes -- I am sorry. 14 because our procedures changed in the last year or two. 15 So DHHS used to issue them directly, I think. 16 the local health department issues them. 17 is for the well owner to work with the local health 18 department on a remediating the water. 19 point, it is re-sampled. 20 Q. I need to correct myself, And now And the intent And at that And so it is resampled -- so you would expect 21 that re-sampling occurred when a "do not drink" letter is 22 received, is that right? 23 24 25 A. After some remediation efforts -- there is an attempt to remediate it. Q. We recommend re-sampling. Did you -- when you issued the "do not drink" MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 96 1 letters for the hexavalent chromium and vanadium, did you 2 recommend that the well owners re-sample their wells? 3 A. In some cases, yes. 4 Q. And why was that? 5 A. There -- some wells were tested at 6 laboratories that couldn't detect hexavalent chromium at 7 a low enough level, and so we couldn't assess the risk. 8 9 10 Q. And in cases where you did not recommend that the well was re-sampled, why was that? A. It should have been because the water was 11 tested at a lab with the ability to detect it at the 12 necessary level. 13 (DEFENDANT EXHIBIT 287 WAS 14 MARKED FOR IDENTIFICATION.) 15 Q. I will show you -- this is Exhibit 287. 16 you would turn to the last page of this exhibit. 17 (Witness peruses document.) If 18 A. Go ahead. 19 Q. This is an e-mail that appears to be sent to 20 you on July 27th, 2015, at 10:46 a.m. Do you see that? 21 A. Yes. 22 Q. Your name is listed as receiving this, 23 correct? 24 A. Yes. 25 Q. Do you recall receiving this? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 97 1 A. Not specifically. 2 Q. Do you see this appears to be a draft e-mail 3 from Kelly -- I am sorry, from Alexandra -- excuse my 4 pronunciation - Lefebvre. 5 A. Yes. 6 Q. Who is that? 7 A. Alexandra Lefebvre is a Press Assistant in the 8 Office of Communications in the North Carolina Department 9 of Health and Human Services. 10 11 Q. And this is in regards to an "Urgent Media Request," based upon the subject line, is that right? 12 A. Yes. 13 Q. And she is asking you to review this draft for 14 any -- well, to determine if it is accurate/appropriate, 15 correct? 16 A. 17 She is asking all of the people, including myself, on that line to do that, yes. 18 Q. 19 Did you review this draft e-mail? (Witness peruses document.) 20 A. I don't remember reviewing it, but I probably 22 Q. Okay. 23 A. I generally review things from the 21 24 25 did. Communication Office marked "Urgent." Q. Do you see where the draft e-mail states that MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 98 1 "sampling of a well only provides a snapshot of the well 2 conditions at the time of sampling"? Do you see that? 3 A. Yes. 4 Q. Do you agree with that statement? 5 A. Yes. 6 Q. "Groundwater constantly flows, resulting in 7 potential changes in the chemical composition of the 8 groundwater." Do you see that? 9 A. Yes. 10 Q. Do you agree with that? 11 A. Yes. 12 Q. And then it says, "Thus, if the contaminant 13 exceeds levels set by regulation in certain cases, or 14 exceeds Health Protective Levels, DHHS recommends 15 re-sampling to ensure that the contaminant is actually 16 present in the well." Do you see that? 17 A. I see that. 18 Q. Do you agree with that? 19 A. We can do that sometimes. 20 We do that sometimes. 21 Q. Do you agree with the statement? 22 A. No. 23 Q. And why don't you agree with that? 24 A. Because we don't always recommend it. 25 Q. Do you sometimes recommend it? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 99 1 A. Yes. 2 Q. To determine if the contaminant is actually 3 4 5 present in the well, correct? A. To determine the level at which the contaminant is present. 6 Q. Correct? 7 A. Yes. 8 Q. Have you ever authored any studies dealing 9 with hexavalent chromium? 10 A. No. 11 Q. Have you ever authored any studies dealing 12 with vanadium? 13 A. No. 14 Q. Have you ever reviewed any studies dealing 15 with hexavalent chromium? 16 A. Yes. 17 Q. What studies? 18 A. I can't remember. 19 titles. I can -- I don't know the I read some papers. 20 Q. And who were those papers authored by? 21 A. I don't remember. 22 Q. Can you tell me if they were authored by a 23 24 25 government agency? A. I read some of the material from EPA. read some academic papers. And I don't know the I also MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 100 1 affiliation -- I don't remember the affiliation of the 2 authors. 3 Q. 4 And how many of these studies have you reviewed? 5 A. I would say fewer than five. 6 Q. When did you review these studies? 7 A. Sometime between January 2015 and June, July Q. Have you reviewed any studies since June or 8 9 10 2015. July of 2015? 11 A. I don't think so. 12 Q. Before January of 2015, have you ever -- had 13 you ever reviewed any studies dealing with hexavalent 14 chromium? 15 A. No. 16 Q. Are you doing any ongoing studies -- you, 17 yourself -- on hexavalent chromium? 18 A. No. 19 Q. Have you ever authored any studies on 20 vanadium? 21 A. No. 22 Q. Have you ever reviewed any studies on 23 vanadium? 24 A. Yes. 25 Q. And when -- how many studies have you MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 101 reviewed? 2 A. I definitely read one. 3 Q. Who authored those studies? 4 A. I don't know. 5 Q. Were those studies by any government agency? 6 A. I don't remember. 7 Q. And when were those reviewed? 8 A. The same time frame. 9 Q. So between January 2015 and June 2015? 10 A. Yes. 11 Q. Before January 2015, had you ever reviewed any 12 I might have read two. studies about vanadium? 13 A. No. 14 Q. Since June of 2015, have you reviewed any 15 studies dealing with vanadium? 16 A. No. 17 Q. And I assume you are not -- you, yourself, 18 aren't conducting any studies related to vanadium? 19 A. No. 20 Q. And have never done so? 21 A. Correct. 22 Q. And have never conducted any studies related 23 24 25 to hexavalent chromium -- you, yourself? A. Correct. (DEFENDANT EXHIBIT 288 WAS MEGAN MARIA DAVIES, M.D. 1 5/4/16 MARKED FOR IDENTIFICATION.) 2 MR. ROSSER: This is 287? 3 REPORTER: 288. 4 BY MR. ROSSER: 5 6 PAGE 102 Q. 288. Dr. Davies, are you familiar with what has been marked as Exhibit 288? 7 (Witness peruses document.) 8 A. Yes. 9 Q. What is this document? 10 A. It is the Interim Report on the study of 11 Standards and Health Screening Levels for hexavalent 12 chromium and vanadium. 13 Q. And this report refers to an Interdepartmental 14 Work Group to conduct the study required by Section 4.8A. 15 Are you familiar with that Interdepartmental Work Group? 16 A. Where does it say that? 17 Q. On the last page, first sentence of the last 18 paragraph. 19 20 21 (Witness peruses document.) A. So you are asking if I am familiar with the Work Group? 22 Q. Correct. 23 A. I am familiar with the statement that there 24 25 would be one. Q. Are you familiar with the Work Group? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 103 1 A. I don't think the Work Group ever formed. 2 Q. And why is that? 3 A. DEQ was the lead agency. And after 4 communicating our availability to participate in the Work 5 Group, we didn't receive invitations to meet. 6 7 8 9 Q. When you say DEQ was the lead agency, what do you mean by that? A. My understanding is that the -- was it a Special Provision that --- 10 (Witness peruses document.) 11 "Section 4.8A of S.L. 2015-286 directed the 12 North Carolina Department of Environment and Natural 13 Resources name change by 2015 legislation to North 14 Carolina Department of Environmental Quality (DEQ) in 15 conjunction with the Department of Health and Human 16 Services to study the State’s Groundwater Standards under 17 15A NCAC 2L or state interim allowable maximum 18 contaminant levels (IMAC) as applicable, as well as state 19 Health Screening Levels for hexavalent chromium and 20 vanadium" -- this is a long sentence -- “relative to 21 other southeastern state standards for these contaminants 22 and the federal maximum contaminate levels (MCL's) for 23 these contaminants under the Safe Drinking Water Act, in 24 order to identify appropriate standards to protect public 25 heath, safety and welfare." I am going to stop at the MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 104 semicolon. 2 So our understanding was DEQ was directed to 3 do this in conjunction. And so we understood DEQ to be 4 the lead agency -- the one with the responsibility to 5 provide the report. 6 (DEFENDANT EXHIBIT 289 WAS 7 MARKED FOR IDENTIFICATION.) 8 9 10 Q. This is 289. Dr. Davies, are you familiar with the document in front of you that has been marked Exhibit 289? 11 (Witness peruses document.) 12 A. Yes. 13 Q. Have you reviewed this document before? 14 A. Yes. 15 Q. The first sentence there reads that, "The 16 current maximum contaminant level for chromium in all 17 forms in drinking water is 100 parts per billion, which 18 includes chromium-6." Do you see that there? 19 A. Yes. 20 Q. Do you agree with that statement? 21 A. Yes. 22 Q. And it says under the question, "Why doesn't 23 EPA regulate chromium-6?" And the answer there given is, 24 "EPA does regulate chromium-6 (or hexavalent chromium) as 25 part of the total chromium drinking water standards since MEGAN MARIA DAVIES, M.D. 1 1992." 5/4/16 PAGE 105 Do you agree with that statement? 2 A. No. 3 Q. Why not? 4 A. Because total chromium is composed of 5 hexavalent chromium and trivalent chromium. 6 amount regulated is not just chromium-6. 7 Q. So the total Then it says, "The current drinking water 8 standard sets the maximum level of total chromium allowed 9 in drinking water, and this standard addresses all forms 10 of chromium, including chromium-6." 11 there? Do you see that 12 A. Yes. 13 Q. Do you agree with that? 14 A. Yes. 15 Q. And then the next sentence says, "Since 16 current testing does not distinguish what percentage of 17 the total chromium is chromium-6 versus chromium-3, EPA's 18 regulation assumes that the sample is 100 percent 19 chromium-6." Do you see that there? 20 A. Yes. 21 Q. Do you agree with that? 22 A. If the EPA states that, I don't disagree with Q. What role do background levels play in setting 23 24 25 it. Health Screening Standards? MEGAN MARIA DAVIES, M.D. 5/4/16 1 A. Could you clarify the question? 2 Q. Sure. PAGE 106 When you are evaluating -- I know you 3 are not -- you don't have the expertise to actually set 4 screening levels, correct? 5 A. Correct. 6 Q. But what -- to your knowledge, how do 7 background levels of constituents play into setting 8 Health Screening Levels, if at all? 9 A. So for Health Screening Levels, they -- it 10 doesn't matter whether the constituents are there in the 11 background or if it was introduced in some other way. 12 Q. So as part of its setting screening levels for 13 the various -- for chromium-6 and vanadium, there has 14 been no assessment by your department as to whether or 15 not Duke's various impoundments have impacted 16 groundwater, correct? 17 A. Correct. 18 Q. How were -- let's start with hexavalent 19 chromium. 20 developed? 21 22 A. So how were these Screening Levels of .07 They were developed in accordance with the North Carolina Administrative Code -- the 2L Rule. 23 Q. And are you familiar with that 2L Rule? 24 A. I have read it. 25 Q. And you, yourself, did not perform the MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 107 calculation, correct? 2 A. No. 3 Q. Who did that? 4 A. The toxicologists at DEQ and the toxicologists 5 at DHHS. 6 Q. 7 8 Okay. What were the names of the folks at DEQ who performed that calculation? A. Hanna Assefa and Dave Lilley -- David Lilley. 9 (DEFENDANT EXHIBIT 290 WAS 10 11 MARKED FOR IDENTIFICATION.) Q. This is 290. Dr. Davies, this is a series of 12 e-mails that has been marked Exhibit 290. 13 is the author of the first e-mail in the chain. 14 the Ms. Assefa that you were referring to earlier? 15 Hanna Assefa Is that (Witness peruses document.) 16 A. Yes. 17 Q. And she is with the North Carolina Division of 18 Waste Management, is that right? 19 A. I believe so. 20 Q. Is David Lilley also with the North Carolina 21 Division of Waste Management? 22 A. I believe so. 23 Q. Who asked them to, if you know, perform this 24 25 particular calculation? A. I don't know. MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 108 It references the use of the California EPA Slope Factor for ingestion. Do you see that? 3 A. Yes. 4 Q. Are you familiar with that Slope Factor? 5 A. No. 6 Q. Do you know how that Slope Factor was reached? 7 A. No. 8 Q. Do you know what studies went out into the use 9 of that Slope Factor? 10 A. No. 11 Q. Do you know if that Slope Factor is reliable? 12 A. We -- I believe it is reliable, because we 13 consulted CDC-ATSDR and they confirmed that was the 14 correct Slope Factor to use. 15 Q. Who at the CDC did you talk to? 16 A. I did not talk to them. I believe it was an 17 e-mail communication between one of our toxicologists and 18 a toxicologist at CDC-ATSDR. 19 Q. Who was the toxicologist --- 20 A. (Interposing) I don't know. 21 Q. --- at -- I am sorry? 22 A. I don't know the name. 23 Q. At DHHS? 24 A. I think it was Sandy Mort. 25 Q. Sandy -- I am sorry? Oh, sorry. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 109 1 A. Mort, M-O-R-T. 2 Q. Was this -- have you seen this e-mail 3 communication from the CDC? 4 A. Yes, I saw it. 5 Q. What did it say? 6 A. I don't remember. 7 Q. Did you see the e-mail communication, I guess, 8 9 10 11 12 from Sandy to the CDC? A. I don't remember exactly. I think I saw the -- the e-mail chain. Q. Has the Department used the California EPA Slope Factor for other screening levels? 13 A. I don't know. 14 Q. Have other -- I am sorry. Have other states 15 used the California EPA Slope Factor for setting Health 16 Screening Levels? 17 A. I don't know. 18 Q. Did you consult with any other states? 19 A. No. 20 Q. Did you consult with EPA? 21 A. No. 22 Q. Did you contact the California EPA? 23 A. I did not. 24 Q. Did anybody in your department? 25 A. I don't know. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 110 1 Q. What are Slope Factors? 2 A. They are a number that quantifies what the 3 slope of a graph is. 4 Q. How are they derived? 5 A. I don't know. 6 Specific to Cancer Slope Factors, I don't know how it is derived. 7 Q. 8 for ingestion? 9 A. I don't know. 10 Q. Did California follow EPA's methodologies? 11 A. I don't know. 12 Q. What are the North Carolina methodologies for 13 How did California develop its Slope Factor developing Slope Factors? 14 A. I don't know. 15 Q. I assume that if I asked you to perform the 16 calculation, you couldn't, sitting here today --- 17 A. Correct. 18 Q. --- for screening levels? 19 If you could go back to the frequently asked questions. 20 (Witness peruses document.) 21 On page 3 -- it is on the bottom last 22 paragraph -- it says, "While North Carolina has a 23 Groundwater Quality Standard of 10 parts per billion that 24 is protective for chromium-6, the Department has 25 developed a Health Screening Level for chromium-6, using MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 111 1 a method consistent with 15A NCAC 02L at 0.07 parts per 2 billion based on its independent review of current 3 literature corresponding to a one in a million lifetime 4 cancer risk level." Do you see that? 5 A. Yes. 6 Q. What is the current literature referenced 8 A. I don't know. 9 toxicologists. 7 there? 10 11 Q. You would have to ask the What is the difference between an IMAC and a Health Screening Level? 12 A. An IMAC is an interim maximum allowable 13 concentration that is -- applies to groundwater, and is 14 set by the Director of the Division of Water Resources 15 pending completion of the whole process to set a 16 regulatory standard. 17 Q. If you could turn to the final report, which 18 is what we previously marked. 19 2016. 20 21 MR. HOLLEMAN: MR. ROSSER: The final report. This is the April 1st, 2016. 24 25 What did you say you were referring to? 22 23 This is dated April 1st, MR. HOLLEMAN: Exhibit. I don't think that is an We haven't talked about it. MEGAN MARIA DAVIES, M.D. 1 MR. ROSSER: 5/4/16 PAGE 112 Okay. 2 (DEFENDANT EXHIBIT 291 WAS 3 MARKED FOR IDENTIFICATION.) 4 BY MR. ROSSER: 5 6 Q. 291? Dr. Davies, are you familiar with the document that has been marked Exhibit 291? 7 A. Yes, I recognize it. 8 Q. Have you reviewed this before? 9 A. I have read through it before. 10 Q. If you could turn to page 3 at the bottom, it 11 says -- and this is in the third sentence of that 12 paragraph. 13 Levels for vanadium and hexavalent chromium were 14 calculated using methodology and toxicity values selected 15 according to the precedence outlined in an agreement 16 between the Department and DEQ Division of Waste 17 Management for the development of Health Risk Evaluations 18 for private well users." 19 there? It says, "The Department Health Screening Do you see that statement 20 A. Yes. 21 Q. What methodology is referenced here? 22 A. The methodology is in some standard operating 23 24 25 procedures at the DEQ Division of Waste Management. Q. And who developed those standard operating procedures? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 113 1 A. I don't know. 2 Q. Are you familiar with them? 3 A. I have seen them. 4 Q. What do they say? 5 A. I haven't read them thoroughly. 6 Q. What toxicity values are referenced in this 7 statement? 8 A. I don't know. 9 Q. What precedence is referenced in this 10 statement? 11 A. It is referencing a letter from Dexter 12 Matthews, who was the Director of the Division of Waste 13 Management, written to me as the Epidemiology Section 14 Chief, laying out an agreement for the Division of Waste 15 Management toxicologist and the Division of Public Health 16 toxicologist to work together. 17 2014. 18 Q. That letter was sent in So you all had reached an agreement to develop 19 an approach to setting Health Screening Levels, is that 20 right? 21 A. Yes. 22 Q. And what was the purpose of that agreement? 23 A. To attempt to have consistency around levels. 24 Q. Why was that? 25 A. We felt it was important to try to be MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 114 1 consistent in order to be able to communicate more 2 clearly with affected people. 3 Q. And when you say "consistency," you mean 4 consistency in communications both from the Department 5 HHS and DEQ? Is that what you mean? 6 A. Yes. 7 Q. Was that agreement adhered to? 8 A. Yes. 9 (DEFENDANT EXHIBIT 292 WAS 10 11 12 MARKED FOR IDENTIFICATION.) Q. 292. Is Exhibit 292 -- is this the letter you were talking about? 13 A. Yes. 14 Q. And I assume you have read this letter, is 15 that right? 16 A. Yes. 17 Q. The second paragraph states that, 18 “Toxicologists in DENR and the Department have agreed to 19 make recommendations on the private wells by comparing 20 contaminant concentrations found in samples of the 21 private wells to, first, the federal maximum contaminant 22 levels adopted by EPA.” Do you see that? 23 A. Yes. 24 Q. What is the federal maximum contaminant level 25 for chromium? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 115 1 A. For total chromium? 2 Q. And that standard, you testified earlier, 3 4 5 6 7 100 micrograms per liter. includes chromium-6, correct? A. Total chromium includes chromium-6 and chromium-3. Q. We can put that aside for now. MR. ROSSER: It is now noon. I probably 8 will take you to 2:30, so if you want to take a break for 9 a brief lunch, we can do that. 10 If you want to forge ahead, I am comfortable with that as well. 11 THE WITNESS: I am okay going ahead. 12 MR. ROSSER: Do you want to take a break, 13 five minutes then? 14 (THE PROCEEDINGS WERE RECESSED AT 12:04 P.M. 15 TO RECONVENE AT 12:46 P.M. THIS SAME DAY.) MEGAN MARIA DAVIES, M.D. 1 F U R T H E R 2 D I R E C T 3 PAGE 116 P R O C E E D I N G S E X A M I N A T I O N 12:46 P.M. (RESUMED) 4 BY MR. ROSSER: 5 6 5/4/16 Q. 279. Dr. Davies, if I could turn your attention to It is one of the "Do not drink" letters. 7 A. Yeah. 8 Q. The constituent that is identified as 9 10 chromium. I assume that is total chromium there; is that what that refers to? 11 A. Yes. 12 Q. Why is that not listed as chromium 6, then? 13 A. Because this is the groundwater standard, 14 which is -- which are those levels that have gone through 15 that regulatory process. 16 Q. Which is listed here as 10 parts per billion, 17 correct? 18 A. Correct. 19 Q. You can correct me if I am wrong, but these 20 letters were sent, as I understand it, based upon the 21 screening level set by the Department of .07; is that 22 right? 23 A. No. 24 Q. These were sent based upon the groundwater 25 standard of 10 parts per billion? MEGAN MARIA DAVIES, M.D. 1 A. No. 5/4/16 PAGE 117 And I am speaking to something that was 2 being done at DEQ. 3 received a set of -- a letter and the results. 4 this -- it depended on what your levels were what 5 specific HRE you got and what -- maybe what it said in 6 this letter. 7 8 Q. But my understanding is everybody So What was this -- this particular letter refers to the 10 parts per billion, correct? 9 A. Yes. 10 Q. And so was this particular letter sent not on 11 12 13 14 15 16 17 18 19 20 21 22 23 the basis of the screening level? A. Everybody got a letter of some sort. So I don't know how to answer that. Q. So you don't know the basis upon which this particular letter was sent? A. My understanding is everybody got a letter with their test results and other materials in it. Q. And when you say "everybody got a letter," who are you talking about? A. Yes. People who had their well water tested under CAMA. Q. And so if this result equals -- indicates a 21.8 total chromium standard; right? 24 A. Yes. 25 Q. And then there is a -- followed by well water MEGAN MARIA DAVIES, M.D. 1 5/4/16 information and use recommendations. 2 A. Yes. 3 Q. Okay. PAGE 118 Do you see that? And that indicates that the following 4 substances -- hexavalent chromium and vanadium -- 5 exceeded the screening levels; correct? 6 A. Yes. 7 Q. But the front page only talks about total 8 chromium, correct? 9 A. Correct. 10 Q. All right. If you turn to page 5 of the Pace 11 Analytical report, total chromium is listed as 21.8, 12 correct? 13 A. Yes. 14 Q. Which would be consistent with the first page, 15 right --- 16 A. Yes. 17 Q. --- of the letter? 18 A. Yes. 19 Q. Then if you go down to hexavalent chromium, 20 that is 22.3. Do you see that? 21 A. Yes. 22 Q. Explain to me how you would have a situation 23 where you would have a total chromium parts per billion 24 number that would be less than a chromium 6 number? 25 A. I don't know how they processed the samples in MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 119 1 the lab and ran the tests, but they could have used 2 different methods that would give you different results. 3 Q. If chromium 6 includes -- well, total chromium 4 includes all of chromium 6 -- you testified to that 5 earlier today; right? 6 A. Yes. 7 Q. This wouldn't seem to make sense, would it? 8 A. I think there is some variability in lab 9 results. 10 Q. Is that what your explanation is? 11 A. Yeah. 12 Q. And how do you account for that variability at 13 issue in these letters? 14 A. That wasn't -- that wasn't addressed. 15 Q. Why not? 16 A. We issued the health risk evaluations, which 17 is the only part of this that DHHS did, based on the 18 measured level compared to a preset health screening 19 level. 20 Q. So I guess -- let me ask it again, because I 21 am not sure I got a clear answer. 22 you, in a lab report, to have a hexavalent chromium parts 23 per billion number higher than a total chromium number? 24 A. Yeah. 25 Q. Why does that make --- Does it make sense to MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 120 1 A. (Interposing) 2 Q. --- sense to you? 3 A. Because laboratory measurements have 4 Yeah. variability in them. 5 Q. Have you ever operated a lab? 6 A. No. 7 Q. Have you ever tested for hexavalent chromium 8 or ran tests for hexavalent chromium or chromium? 9 A. No. 10 Q. So what variability are you qualified to talk 11 12 about here today? A. I am speaking from my experience as a 13 clinician who has reviewed a lot of clinical lab results 14 that often have variability in them. 15 qualified to comment on the methods of water chemistry 16 analysis. 17 18 Q. But I am not Have you ever seen a lab report that contains higher levels of hexavalent chromium than total chromium? 19 A. Well, right now. 20 Q. Other than the one before you? 21 A. No. 22 Q. Dr. Davies, do you agree that municipal water 23 supplies in North Carolina contain levels of hexavalent 24 chromium in excess of the Department screening level? 25 A. Yes. MEGAN MARIA DAVIES, M.D. 1 Q. 5/4/16 PAGE 121 And what studies did the Department undertake 2 to evaluate those levels before issuing its screening 3 levels? 4 A. None. 5 Q. If we could go back to --- 6 A. (Interposing) 7 Q. --- the frequently asked questions, page 4. 8 None that I know of. And do you see the chart there on page 4? 9 A. Yes, I do. 10 Q. Do you agree that the levels as indicated here 11 in Atlanta are higher than the screening levels set by 12 the Department for chromium 6? 13 A. Yes. 14 Q. Do you agree that there have been levels 15 measured in North Carolina that exceed the screening 16 levels for chromium 6 in Charlotte? 17 A. Yes. 18 Q. Do you agree that the screening levels for 19 Chicago, Illinois exceed the screening levels -- or, I am 20 sorry, the levels of chromium 6 in Chicago have exceeded 21 the screening levels set by DHHS? 22 A. Yes. 23 Q. And in Greensboro, North Carolina, do you also 24 agree that there has been measurements exceeding the 25 chromium 6 levels set by the Department? MEGAN MARIA DAVIES, M.D. 5/4/16 1 A. Yes. 2 Q. And in Honolulu, Hawaii, as well? 3 A. Yes. 4 Q. And Madison, Wisconsin? 5 A. Yes. 6 Q. And Norman, Oklahoma? 7 A. Yes. 8 Q. And Raleigh, North Carolina? 9 A. Yes. 10 Q. And Riverside, California? 11 A. Yes. 12 Q. 293. PAGE 122 13 (DEFENDANT EXHIBIT 293 WAS 14 MARKED FOR IDENTIFICATION.) 15 16 Dr. Davies, are you familiar with the document that has been marked Exhibit 293? 17 (Witness peruses document.) 18 A. No. 19 Q. If you could turn to page 10 of that document, 20 do you see that chart there? 21 A. Yes. 22 Q. Do you see where it says, "California proposed 23 safe limit"? 24 A. Yes. 25 Q. All right. And do you agree that this chart MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 123 1 shows that 24 of the 31 cities' tap water exceeded .07 2 screening level for hexavalent chromium? 3 A. You have to be patient while I count. 4 MR. HOLLEMAN: What is the Exhibit Number? 5 REPORTER: 293. 6 THE WITNESS: 24 exceed .07. 7 BY MR. ROSSER: 8 9 10 Q. What is the Department doing to address hexavalent chromium levels above .07 in public water supplies? 11 A. What department? 12 Q. DHHS. 13 A. We are not working on public water supplies. 14 Q. So nothing? 15 A. Correct. 16 Q. How many private wells are there in North 17 Carolina? 18 A. I don't know the number. 19 Q. Can you approximate? 20 A. I can approximate it is a lot. 21 Q. Any more specific than that? 22 A. No. 23 Q. What is the Department -- DHHS doing to 24 address hexavalent chromium levels and vanadium levels in 25 private wells throughout the state? MEGAN MARIA DAVIES, M.D. 1 2 A. 5/4/16 PAGE 124 We are not doing anything, with the exception of wells tested under CAMA. 3 Q. And why is that? 4 A. Actually, I need to restate that. We are not 5 doing that except for wells that have been tested for 6 hexavalent chromium. 7 not tested for it. 8 9 10 Q. So most wells -- private wells, are And so the Department is not doing anything to address private wells, other than those designated under CAMA; is that correct? 11 A. No. 12 Q. Let me rephrase that. Other than those 13 designated under CAMA, what is DHHS doing to address 14 hexavalent chromium levels and vanadium levels in private 15 wells in North Carolina? 16 A. In those cases where a well was tested for 17 hexavalent chromium and brought to the attention of DHHS, 18 we either directly sent an HRE similar to the ones sent 19 for wells tested under CAMA, or the local health 20 department did. 21 Q. 22 23 MR. HOLLEMAN: (Interposing) Well, what -- I am sorry, the answer? 24 25 So I will refer to these as --- THE WITNESS: did. Or the local health department MEGAN MARIA DAVIES, M.D. 1 2 5/4/16 PAGE 125 BY MR. ROSSER: Q. I will offer these as non-CAMA wells, which 3 are -- you have testified that there is a lot of these 4 wells throughout the state. 5 tested for hexavalent chromium? How many of those wells are 6 A. Very few. 7 Q. How many of those wells are tested for 8 vanadium? 9 A. Very few. 10 Q. And in the few instances those are tested, 11 under what circumstances would that occur? 12 A. If the well owner specified that -- that 13 testing. 14 Q. This would be a voluntary test? 15 A. Yes. 16 Q. Not one that is required under law? 17 A. Yes. 18 Q. And you have testified earlier that new wells 19 do not even test for hexavalent chromium or vanadium, 20 correct? 21 A. Correct. 22 Q. So if I have an existing well -- older well 23 that I have already tested, do older wells in North 24 Carolina have to be tested under law for hexavalent 25 chromium or vanadium? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 126 1 A. No. 2 Q. Why is that? 3 A. I don't know. 4 Q. So this .07 -- I just want to understand how 5 this risk assessment works, because I am clearly not a 6 toxicologist or epidemiologist. 7 level .07 is based upon increased risk of one in a 8 million; correct? But if I -- so this 9 A. Correct. 10 Q. For lifetime use? 11 A. Correct. 12 Q. So if this cup of water in front of me 13 contains .08 parts per billion of chromium 6, if I take 14 one sip of it, have I then increased my chance of getting 15 cancer? 16 A. It depends. 17 Q. Okay. 18 A. On if that sip resulted in a change to your 19 20 21 Depends on what? DNA that would set in progress progression to cancer. Q. Okay. Assuming it does, would that one sip increase my risk of getting cancer? 22 A. If it altered your DNA, yes. 23 Q. At .08 parts per billion? 24 A. Yes. 25 Q. Okay. Same question for .06? MEGAN MARIA DAVIES, M.D. 1 A. Yes. 2 Q. It would? 5/4/16 PAGE 127 It would -- if this contained 3 hexavalent chromium at a level of .06, but below the 4 screening level that DHHS set, and it altered my DNA 5 somehow, that would increase my chance of getting cancer; 6 is that right --- 7 A. Yes. 8 Q. --- based upon one sip? 9 A. It could. 10 Q. What about .01? If I took one sip of this 11 water and it contained .01 parts per billion of 12 hexavalent chromium, and it altered my DNA in some 13 fashion, would that increase my chance of getting cancer? 14 A. Yes. 15 Q. Going back to the .08 parts per billion, if 16 this cup of water contains .08 parts per billion of 17 hexavalent chromium, is this water unsafe to drink? 18 one -- just one sip? 19 20 A. Just It is above the screening level, and relatively less safe than a lower level. 21 Q. Is it unsafe? 22 A. I don't know. 23 Q. Why not? 24 A. Because I don't know whether that cup of water 25 is safe for you to drink or not. MEGAN MARIA DAVIES, M.D. 1 Q. 5/4/16 PAGE 128 Well, assuming it has got a .08 parts per 2 billion level of hexavalent chromium, is this water safe 3 to drink? 4 5 A. It does not meet the health risk evaluation standard. 6 Q. Is that a "yes," it would be unsafe to drink? 7 A. I am uncomfortable with the words "safe" and 8 "unsafe." 9 which, you know, is not a desirable outcome. 10 Q. You would be at increased risk of cancer, Okay. Now let's go to .06, which is below the 11 screening level. 12 water, it will increase my chances of getting cancer, 13 correct? 14 A. Right. 15 Q. Is .06 unsafe to drink? 16 A. A .06 has a risk associated with it of 17 developing cancer. 18 million. 19 Q. You already told me if I drink this 20 21 22 It is something less than one in a And so let's go to .01. Is that water unsafe to drink? A. That drink also has a risk that is less than one in a million. 23 Q. But there is still a risk, correct? 24 A. Correct. 25 Q. A risk of increased risk of getting cancer, MEGAN MARIA DAVIES, M.D. 5/4/16 1 correct? 2 A. Correct. 3 Q. Well, let me ask you this. 4 PAGE 129 What are the standards for chromium 6 in bottled water? 5 A. I don't believe there are any standards. 6 Q. What are the standards for total chromium in 7 bottled water? 8 A. I don't believe there are any standards. 9 Q. Do the federal drinking water standards apply 10 to bottled water? 11 A. No. 12 Q. They do not? 13 A. I don't think so. 14 Q. Okay. So a company is free to put in whatever 15 water it wants to, regardless of the amount of 16 contaminants in bottled water? 17 A. So I am going by what I have heard Bob 18 Midgette say at DEQ, that -- that bottled water isn't 19 regulated the way public water supplies are. 20 know what regulation bottled water goes -- is under, from 21 FDA or USDA or whomever might regulate that consumer 22 product. 23 Q. Do you consider it unsafe to drink bottled A. Generally, no. 24 25 water? I don't MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 130 1 Q. Do you, yourself, drink bottled water? 2 A. Sometimes. 3 Q. What is the basis of your view that bottled 4 water is generally safe to drink? 5 A. So I am -- can you clarify that question? 6 Q. I asked you if you think bottled water is 7 safe -- or unsafe, sorry, and you said, "generally, no." 8 And I am asking for the basis for that opinion. 9 A. I haven't seen a lot of outbreaks associated 10 with bottled water. I haven't seen studies correlating 11 disease to bottled water. 12 Q. Anything else? 13 A. No. 14 Q. How does the .07 screening level for 15 hexavalent chromium compare with other states? 16 17 A. Most states don't have established health screening level for hexavalent chromium. 18 Q. How many states do? 19 A. I only know of California having a regulatory 20 level and a health goal. 21 Q. How about the other 48 states? 22 A. I don't know of them having a health screening 24 Q. Did you look into that? 25 A. Yes. 23 level. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 131 1 Q. What was your findings? 2 A. That there weren't -- we didn't find any 3 4 others besides California. Q. Other than -- I guess you testified that the 5 CDC was consulted. Did you consult EPA on the hexavalent 6 chromium screening level? 7 A. I don't know if my staff did. 8 Q. What about other states? 9 A. I don't think so. 10 Q. What is the current status of federal 11 regulation of chromium 6? 12 A. It is being reviewed by the EPA. 13 Q. Do you have any other information? 14 A. Not that I can speak to authoritatively. 15 Q. How were the screening levels developed for 16 vanadium? 17 A. We used the IMAC as referenced in CAMA. 18 Q. What is that level? 19 A. 0.3 micrograms per liter. 20 Q. If you would go back to the "Frequently Asked 21 Questions" document, page 3. And in the footnote at the 22 bottom says, "An IMAC is based upon the scientific 23 information available at the time of its development, but 24 is not the subject to the rigorous review associated with 25 established groundwater standards.” Do you see that? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 132 1 A. Yes, I do. 2 Q. What is the difference -- I mean, talk to me 3 about the levels of review when compared to setting 4 groundwater -- let me ask that in a question. 5 groundwater standards in North Carolina subject to more 6 rigorous review than an IMAC? 7 8 9 10 A. This isn't my area of expertise. How are I don't promulgate those kinds of standards. Q. You don't have expertise in setting IMAC standards? 11 A. That is correct. 12 Q. So you don't know the answer to my question? 13 A. I don't know it. 14 Q. What studies were considered in setting the 15 16 17 screening levels for vanadium? A. You would have to ask the toxicologist at DW -- DWM and DEQ. 18 Q. You don't know? 19 A. I don't know. 20 Q. What studies were rejected in setting levels 21 for vanadium at the Department? 22 A. I don't know. 23 Q. There is no federal drinking water outstanding 24 25 for vanadium; is that right? A. That is correct. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 133 1 Q. Why not? 2 A. I don't know. 3 Q. Have you looked into that? 4 A. No. 5 Q. How is the vanadium standard calculated? 6 A. I don't know. 7 Q. You couldn't perform the calculation? 8 A. No. 9 Q. How does the .3 parts per billion screening 10 level compare with other states for vanadium? 11 A. I don't know. 12 Q. How many other states have screening levels 13 14 15 for vanadium? A. I don't know, but I think it is in the report to the General Assembly. 16 (Witness peruses document.) 17 So the report states that none of the 18 Southeastern states have adopted vanadium criterion 19 regulation. 20 question? 21 22 Q. I am sorry, was -- can you repeat your I have lost track of it. Yes. How many other states have set screening levels for vanadium? 23 A. I don't know. 24 Q. How many of the states in the Southeast have 25 set screening levels for vanadium? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 134 1 A. Are you talking about health screening levels? 2 Q. Correct. 3 A. So I think the answer to that is none have 4 established health screening levels. 5 Q. Do you know why? 6 A. No. 7 Q. Did you consult with the other states in the 8 Southeast? 9 A. No. 10 Q. Vanadium appears in vitamins, correct? 11 A. Yes. 12 Q. At levels above the DHHS screening level? 13 A. Yes. At levels above the IMAC. 14 MR. HOLLEMAN: I am sorry. 15 THE WITNESS: I said, "Yes. 16 What did you say? At levels above the IMAC." 17 BY MR. ROSSER: 18 Q. Back to the "Frequently Asked Questions," on 19 page 3, "What is vanadium?" 20 there? Do you see that question 21 A. Yes. 22 Q. It says, "Daily intakes of vanadium from food, 23 ranging from 10 to 20 parts per billion have been 24 reported." 25 A. Do you see that? Yes. MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 135 Do you have any reason to disagree with that statement? 3 A. No. 4 Q. Do you agree with that statement? 5 A. And then it says, "National average of 6 vanadium concentrations in tap water are approximately 7 one part per billion; do you see that? 8 A. Yes. 9 Q. Do you have any reason to disagree with that? 10 A. No. 11 Q. Who was consulted in connection with setting 12 13 the screening level for vanadium? A. Division of Public Health leadership and 14 Department of Health and Human Services leadership were 15 consulted in using the IMAC. 16 Q. Who, specifically? 17 A. Chris Hoke, in the Division of Public Health, 18 and Danny Staley. 19 Q. Anyone else? 20 A. I think that is it for the Division of Public 21 Health. 22 we met with Emory Milliken and discussed it. 23 24 25 Q. In the Department of Health and Human Services, I believe you testified Staley is a toxicologist; is that --A. (Interposing) No. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 136 1 Q. He is not? 2 A. He is the Director of the Division of Public 3 Health. 4 Q. Is Mr. Hoke a toxicologist? 5 A. No. 6 Q. What about Mr. -- is it Mr. Milliken or Ms.? 7 A. Emory Milliken, it is a female. He is a lawyer. She is 8 general counsel to the Department of Health and Human 9 Services. 10 Q. And anyone else? 11 A. We had several discussions with leadership of 12 the Department of Health and Human Services, including 13 Dr. Aldona Wos, who was then the Secretary, Matt McKillip 14 (phonetic). 15 other people, but those are the ones I remember for sure. 16 Those are -- there -- there probably were Q. What about EPA? 18 A. No. 19 Q. What about other states? 20 A. No. 21 Q. What about CDC? 22 A. No. 23 Q. If you could go to the April 1st, 2016 report. 24 A. Okay. 25 Q. Have you seen this -- well, I asked you that, 17 Did you consult with them at all? Oh, okay. That is fine. MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 137 but have you read this document before? 2 A. I have read through it. 3 Q. At the bottom of page 6 -- this is under the 4 heading, "Survey of Other States' Criteria" -- do you see 5 that? 6 A. Yes. 7 Q. It says, "None of the Southeastern States have 8 adopted vanadium criteria in regulation.” You -- I 9 believe you testified to that earlier; correct? 10 A. Yes. 11 Q. Then it goes on to say, "North Carolina's IMAC 12 was established at the request of DEQ in 2010." Is that 13 the Department -- what does "DWM" stand for there? 14 A. On page 7? 15 Q. We are on still page 6. 16 A. Oh, Division of Waste Management. 17 Q. Then it says, "This IMAC of .3 parts per 18 billion could be revised on the basis of published and 19 peer-reviewed toxicity information that has become 20 available since 2010"; do you see that? 21 A. Yes. 22 Q. Do you agree with that statement? 23 A. Yes. 24 Q. And tell me -- explain to me why you agree 25 with that. MEGAN MARIA DAVIES, M.D. 1 A. 5/4/16 PAGE 138 Because the toxicologists in OEEB -- 2 Occupational Environmental Epidemiology Branch -- 3 calculated a health screening level -- you know, the IMAC 4 could be revised because that is allowed for in the 5 process. 6 Sorry. 7 8 Q. Does -- that answers your actual question. And what peer-reviewed toxicity information is referenced there? 9 A. Referenced here in this document? 10 Q. Right. 11 (Witness peruses document.) 12 A. I don't see the reference. 13 Q. All right. 14 what peer-reviewed information is referenced there? 15 16 Do you know, sitting here today, A. I don't know what peer-reviewed information is referenced in this report. 17 Q. And then it says that, “As a function of this 18 report, staff have reviewed the newly available toxicity 19 information for vanadium and can currently recommend a 20 revised criterion of 20 parts per billion”; do you see 21 that? 22 A. Yes. 23 Q. And is that the position of HHS? 24 A. No. 25 Q. What is the position of HHS? MEGAN MARIA DAVIES, M.D. 1 A. 2 being revised. 3 Q. 4 5/4/16 PAGE 139 I don't think HHS has a position on the IMAC So you are saying you don't agree with it, but you don't disagree with it? 5 MR. HOLLEMAN: Object to the form. 6 MR. ROBBINS: Objection. 7 MS. LeVEAUX: Objection. 8 THE WITNESS: Yeah. 9 BY MR. ROSSER: 10 Q. That you are not taking a position? 11 A. Yes. 12 MR. HOLLEMAN: Object to the form. 13 MR. ROBBINS: Objection. 14 MS. LeVEAUX: Objection. 15 BY MR. ROSSER: 16 Q. And why aren't you taking a position? 17 MR. HOLLEMAN: Object to the form. 18 MR. ROBBINS: Objection. 19 THE WITNESS: Because you are asking about 20 the establishment of an IMAC by DEQ. 21 role I am engaged in. 22 23 And that is not a BY MR. ROSSER: Q. Do you agree that municipal water supplies in 24 North Carolina contain levels of vanadium in excess of 25 the DHHS screening level of .3 parts per billion? MEGAN MARIA DAVIES, M.D. 1 A. 5/4/16 PAGE 140 I agree that there are municipal water 2 supplies that contain vanadium in excess of .3 micrograms 3 per liter, or parts per billion. 4 5 6 Q. What was your involvement in issuing the "Do not drink" letters? A. I was part of the Public Health Team that 7 consulted or discussed with the Department appropriate 8 action for wells that had a level above the screening 9 levels. 10 11 Q. And did you have any involvement in actually drafting the letters? 12 A. In the Health Risk Evaluation form? 13 Q. In the -- that were sent to the well owners? 14 A. So I have a role in drafting the health risk 15 evaluation form that was sent to the owner, but not the 16 cover letter. 17 recommendations for inorganic chemical contaminants is 18 the document I had a role in. 19 20 Q. So the well water information and use That would be the document that has the title, "Well Water Information and Use Recommendations"? 21 A. Yes. 22 Q. You drafted this? 23 A. I reviewed drafts of it and had input. 24 Q. And it references, "inorganic chemical 25 contaminants." What does "inorganic" mean? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 141 1 A. Means it is not a carbon-based. 2 Q. It is carbon -- so, okay. So this is going to 3 show my ignorance, but -- so if both hexavalent chromium 4 and vanadium are naturally occurring, could they -- could 5 that be considered an organic chemical? 6 A. Not in chemical terms, no. 7 Q. Why is that? 8 A. Because organic chemistry, all the chemicals 9 10 11 12 are carbon-based -- or they have a carbon in their structure. Q. Are hexavalent chromium -- I don't know this -- are they carbon-based? 13 A. No. 14 Q. Is vanadium carbon-based? 15 A. No. 16 Q. But they still are naturally occurring --- 17 A. Yeah. 18 Q. --- in soils, et cetera? 19 A. Yes. 20 Q. The letters were sent, it appears to be, based 21 upon a single sample; is that accurate? 22 A. For the most part, yes. 23 Q. You say for the most part. 24 25 Some were based on multiple samples? A. Some wells were resampled because a lab was MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 142 1 used that didn't have sufficient sensitivity in their 2 method to detect levels low enough. 3 Q. And I am looking at what has been marked as 4 284, 285, and 279. The results for total chromium on 5 these documents indicate 21.8, 22.1, and 17.1? 6 A. Yes. 7 Q. For purposes of the federal drinking water 8 standards, would those levels comply with the standard 9 for total chromium? 10 A. That -- those levels do not exceed the minimum 11 contaminant level -- or maximum contaminant level -- the 12 MCL of the -- under the Safe Drinking Water Act. 13 Q. So that would comply with those standards? 14 A. Correct. 15 Q. If you had a result of 99 for hexavalent 16 chromium -- parts per billion -- would that comply with 17 the standard for total chromium under the federal Clean 18 Water Drinking Act? 19 A. The -- my understanding is it is two different 20 things. 21 Safe Drinking Water Act, because there is no standard for 22 hexavalent chromium. 23 Q. So it would not be out of compliance with the Let's turn back to the April 1, 2016 report. 24 If you could turn to page 11, there is a series of 25 recommendations. Do you see those? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 143 1 A. Yes. 2 Q. It says that DHHS should include improved risk 3 communication plan for its health risk evaluations. 4 you see that? Do 5 A. Yes. 6 Q. Does DHHS plan to follow that recommendation? 7 A. I don't think we have a specific plan. 8 Q. Let me ask my question again. 9 10 11 12 Is DHHS planning to follow this recommendation? A. Of an improved risk communication plan? I don't know. Q. And then it says, "DHHS recommendations for 13 public and private water well use should be uniformly 14 based upon federal MCLs established by the Safe Drinking 15 Water Act." Do you see that there? 16 A. I do. 17 Q. Is DHHS planning to follow that 18 recommendation? 19 A. I don't know. 20 Q. And why don't you know? 21 A. Because I haven't been part of any of those 22 conversations. 23 Q. Are those conversations happening? 24 A. I don't know. 25 Q. Would you expect to be involved in those MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 144 1 communications? 2 A. As state epidemiologist, I would expect to be. 3 Q. Have you done anything in response to these 4 recommendations? 5 A. That is the only DHHS one. 6 Q. Are you planning to do anything in response to 7 I don't think so. the recommendations? 8 A. I don't know what the Agency is planning to Q. When you say "the Agency," who are you talking 12 A. DHHS. 13 Q. You don't know what they are planning to do? 14 A. Correct. 15 Q. Have you talked to anyone about these 9 do. 10 11 16 about? recommendations? 17 A. When they first came out, we were -- I was 18 asked to -- well, before they -- I was asked to review 19 them. 20 about how we would respond to them. 21 22 But we -- I don't remember having a conversation Q. So you had an opportunity to review this before it was submitted to the legislation, right? 23 A. I had an opportunity. 24 Q. Okay. 25 Did you have any specific comments on recommendation number one? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 145 1 A. I did not have any specific comments. 2 Q. And this report was submitted pursuant to 3 session law -- I am looking at the cover letter here -- 4 2015-286? 5 A. Yes. 6 Q. In conjunction with the Department of Health 7 and Human Services, correct? 8 A. That is the wording of the session law. 9 Q. 294. 10 (DEFENDANT EXHIBIT 294 WAS 11 MARKED FOR IDENTIFICATION.) 12 Dr. Davies, have you see Exhibit 294 before? 13 (Witness peruses document.) 14 A. Yes, I have. 15 Q. And what is this you are looking at? 16 A. It is a document with a title, "Well Owners in 17 Disbelief about State's Decision to Lift Tainted Water 18 Warning." 19 20 Q. And did you read this article around the time it was published? 21 A. Yes. 22 Q. And if you would turn to page -- this was 23 published, according to this, on March 19th of 2016, 24 correct? 25 A. That is what is on the paper. MEGAN MARIA DAVIES, M.D. 1 Q. 5/4/16 PAGE 146 If you would look at page 5 of 6, at the 2 bottom, it refers to spokeswoman Alexandra Lefebvre as 3 the DHHS spokesman, correct? 4 A. Yes. 5 Q. She speaks on behalf of DHHS? 6 A. Yes, she does. 7 Q. And she says that, "It is important to 8 understand that it was not one person who created the 9 original levels for usage recommendation, nor was it one 10 person who decided to update the recommendations." 11 you see that? 12 A. Yes. 13 Q. Do you agree with that statement? 14 A. Yes. 15 Q. And then she says, "This was a Department 16 Decision made after consulting with multiple experts 17 across two agencies." Do Do you see that? 18 A. Yes. 19 Q. Do you agree with that --- 20 A. Yes. 21 Q. --- statement? 22 And then there is a reference to a Nancy Holt? 23 A. Yes. 24 Q. Do you know Ms. Holt? 25 A. I do not. MEGAN MARIA DAVIES, M.D. 1 Q. 5/4/16 PAGE 147 She says at the bottom here, that, "None of 2 the people (staff) in DHHS had anything to do with the 3 change." 4 A. No. 5 Q. Ms Holt said, according to this article, that Do you agree with that statement? 6 DHHS staff members she talked to last week are upset 7 because they were not consulted, although Holt declined 8 to provide any names. 9 your staff talking to Ms. Holt? 10 A. Are you aware of any members of I am not. 11 (DEFENDANT EXHIBIT 295 WAS 12 MARKED FOR IDENTIFICATION.) 13 14 Dr. Davies, do you recognize what has been marked as Exhibit 295? 15 A. Yes, I do. 16 Q. In the -- Ms. Shehee -- I am sorry, Dr. 17 Shehee’s e-mail to you on August 21st, 2015, at 6:49 18 a.m., she states that you had mentioned last night about 19 looking into the possible health effects associated with 20 coal ash ponds. 21 with Dr. Davies [sic] -- or Dr. Shehee? Do you remember having that conversation 22 A. I do. 23 Q. What did you say during that conversation? 24 A. I don't remember all the details, but I was 25 reviewing with her requests from Secretary Brajer to look MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 148 1 at any health effects that might have -- to look to see 2 if we could see any health outcomes in the populations in 3 the area of the coal ash ponds. 4 5 Q. And who had made that -- or who had made that request; I am sorry? 6 A. Secretary of DHHS, Rick Brajer. 7 Q. And that request was made directly to you? 8 A. Yes. 9 Q. When was that request made? 10 A. In a meeting, probably -- based on how I 11 normally operate, I called her Thursday, the 20th, to 12 discuss this, I probably -- that is probably when I met 13 with the Secretary. 14 not absolutely certain about that, though. 15 Earlier that day, probably. I am Q. And how did the Secretary's request come to 17 A. In the course of the meeting. 18 Q. And what exactly did he say to you? 19 A. So it is not -- it can't possibly be a direct 16 you? 20 quote, since this -- we are talking about August 2015. 21 In essence, he asks us to look to see if we saw any 22 adverse health outcomes in people living around or near 23 coal ash ponds that would be anticipated, based on the 24 risks identified in the toxicologic literature. 25 Q. And what was your response to the request? MEGAN MARIA DAVIES, M.D. 1 A. 5/4/16 PAGE 149 I indicated that there were severe limitations 2 to attempting to characterize relationship between health 3 outcomes and residents in that area -- current residents 4 in that area to a specific exposure. 5 Q. And what are some of those severe limitations? 6 A. So --- 7 Q. (Interposing) 8 9 Or what -- let me strike that. What are those severe limitations? A. Studies of health outcomes from environmental 10 exposures need to take into account a lifetime of 11 exposure. 12 where they work, what their daily habits are that could 13 potentially expose them to the substance you are 14 concerned about. 15 extremely expensive. 16 complicated epidemiologic study more suited to an 17 academic institution. So you need to know where people have lived, And to conduct that kind of study is And technically, it is a 18 Q. Any other severe limitations? 19 A. It is an ecological study. 20 Q. How long would a study like that take? 21 A. Well, so what -- there is more than one kind 22 of study you can do. An ecological study is usually what 23 people start with. 24 look at measures of exposure in an area, and you look at 25 measures of disease in a population, but you can't And the problem with that is that you MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 150 1 analyze it down to the individual. 2 conclude that the individual outcome is the result of an 3 individual exposure. 4 fallacy. 5 Therefore, you cannot It is called the ecological The other kinds of studies, where you can 6 actually follow individual exposures and individual 7 outcomes, the ideal way to do that is in a prospective 8 cohort study. 9 outcomes like cancer, that could take decades. And that could -- when you are looking at 10 Q. How many decades? 11 A. Many decades. 12 Q. 50 years, 40 years? 13 A. Yeah, on the order of 50 years. 14 Q. And any other severe limitations that you can 15 think of? 16 A. Those are the main ones. 17 Q. And so would you --- 18 A. (Interposing) 19 Q. Sure. 20 A. --- the absence of biomarkers. Actually, let me just add --- Ideally, you 21 would want to be able to measure persons exposed, you 22 would want to be able to measure evidence of the 23 substance in the person. 24 some sort, like a blood level, but for whatever chemical 25 you were interested in, and then the health outcome. That would be a biomarker of MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 151 And that is how you can link one to the next 2 to the next. 3 resources or technology. 4 Q. So we can't do that. We don't have the And so when you expressed the severe 5 limitations to the Secretary, what was his response to 6 you? 7 A. He acknowledged those limitations, but was 8 interested to see what, at least, we could find from 9 looking at the cancer registry, reports of cancers of 10 people who reside in those areas. 11 Q. When you say "those areas," what do you mean? 12 A. I don't remember the geographic -- when we 13 made the actual request of the cancer registry, how they 14 broke down the geographic area. 15 -- sorry, I did air quotes -- near coal ash impoundments. But people living "near" 16 Q. How close? 17 A. That is what I -- I don't remember, off the 18 top of my head. 19 Q. When it says within the e-mail that Rick will 20 provide locations to CCR," these are the locations, I 21 presume, where coal ash impoundments are in North 22 Carolina? 23 A. Yes. 24 Q. And "CCR" is a Cancer registry. 25 State-run registry? Is that a MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 152 1 A. Yes, it is. 2 Q. And then she says that, "vanadium is another 3 leading contaminant. 4 really vague." 5 A. Yes. 6 Q. Is vanadium known to cause cancer? 7 A. No. 8 Q. And its non-cancer effects, you agree with, 9 However, its non-cancer effects are Do you agree with that statement? are really vague? 10 A. They are --- 11 Q. (Interposing) 12 A. Vanadium health effects have been observed in Explain that, what that means. 13 toxicologic studies involving animal models and affect 14 kidneys and blood cells. 15 Q. Have they been tested in human models? 16 A. No. 17 Q. Okay. We don't test in human models. That displayed my ignorance there. 18 Well, let me ask this in this way. Has there been any 19 studies showing the effects -- cancer-related effects on 20 humans as a result of vanadium? 21 A. No. 22 Q. If you would turn to page -- it is number 29 23 on this exhibit, at the bottom. 24 A. Yes. 25 Q. Okay. Do you see that? Dr. Shehee's e-mail to Rick Langley MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 153 1 indicates that the -- essentially to go ahead and request 2 the study, right? 3 A. Yes. 4 Q. Is that right? 5 And she indicates that there is a very short deadline; is that right? 6 A. Yes. 7 Q. Why was there a short deadline? 8 A. Because it was requested by the Secretary of 9 Health and Human Services. 10 Q. Did the Secretary request a short deadline? 11 A. I don't remember him specifically requesting a 12 short deadline. 13 Q. 14 imposed? 15 A. And explain to me why a short deadline was Because when the Secretary of the Department 16 requests information for policymaking, people who work in 17 the Department prioritize that over other work. 18 19 Q. But there was no specific direction from the Secretary to conduct this study on a very short deadline? 20 A. No. 21 Q. And then there was as deadline imposed of 22 September 2nd; is that right? 23 A. That is in my e-mail. 24 Q. So despite your, I think you said, "severe 25 limitations," as expressed to the Secretary, the MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 154 1 Secretary ultimately decided to go ahead with the study; 2 is that right? 3 A. Yes. 4 Q. And have you seen a copy of the study? 5 A. I haven't. 6 Q. Let me ask you this. 7 Why did the Secretary want this study conducted? 8 A. I don't know. 9 Q. Did you ask him? 10 A. I did not ask him why he wanted it. 11 Q. And he didn't tell you why? 12 A. He told me in a conversation he expressed 13 curiosity as to whether we had seen any increase in 14 cancer cases around -- in the areas around coal ash 15 ponds. 16 Q. He said he is curious? 17 A. He was -- wanted to know if there were -- if 18 we have seen increases in cancer cases. 19 context of, when I explained my caveats of performing a 20 cancer cluster analysis, he expressed the desire to at 21 least confirm that there were not strikingly high levels 22 occurring that might need immediate action. 23 24 25 Q. And so this was -- this was outside DHHS's work under CAMA; is that right? A. He put it in the Correct. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 155 1 Q. This was a separate request? 2 A. It came out of the issue -- these issues being 3 raised. 4 Q. But it wasn't required under CAMA? 5 A. No, it wasn't required under CAMA. 6 (DEFENDANT EXHIBIT 296 WAS 7 MARKED FOR IDENTIFICATION.) 8 Q. I have handed you Exhibit 295 -- 296. 9 A. Yes. 10 Q. Is this the study that you request or the 11 Secretary requested? 12 A. Yes. 13 Q. And did you review this study once it was 14 produced? 15 A. I read it, yes. 16 Q. What did the study find? 17 A. It found that, when comparing 95 percent 18 confidence intervals for the five-year age adjusted 19 rates, 2009 to 2013, incident rates for lung, bronchus 20 cancer in Gaston, Rockingham, and Stokes Counties are 21 significantly higher than the state rate. 22 rate for prostate cancer in Robeson County is also 23 significantly higher than the state rate. 24 25 The incidence Given the number of rates being compared, this may just reflect the random distribution of the cancer MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 156 1 incidence rates. Also noted that some of these 14 2 counties had incidence rates significantly lower than the 3 state rate. 4 associated with environmental factors, which is a set of 5 cancers they routinely look at in these requests, when 6 comparing the 95 percent confidence intervals for the 7 five-year age adjusted rates, 2009 to 2013, the incidence 8 rate for liver cancer in Gaston County is significantly 9 higher than the state rate. Additionally, when looking at cancers And the multiple myeloma 10 incidence rate in Wayne County is significantly higher 11 than the state rate. 12 Again, given the numbers of rates being 13 compared, this may just reflect the random distribution 14 of the cancer incidence rates, and that some of the 15 counties had incidence rates significantly lower than the 16 state rate. 17 Q. So both of the Table 1 and Table 2s have a 18 caveat associated with them, that given the number of 19 rates being compared, this may just reflect the random 20 distribution of the cancer incidence rates. 21 that? 22 What is Explain what that means. A. Statistically, what this -- what the cancer 23 registry does is look for statistical anomaly: something 24 that is higher or lower, although in cancer rates, you 25 are looking for higher than an average. It could be MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 157 1 national, it could be state. 2 routinely use the state. 3 time periods and compare the rates in the same geographic 4 area. 5 It could be based -- they Sometimes they use different So there are different ways that you compare 6 one rate to another and do a statistical test of the 7 probability that the difference between those rates is 8 due to random chance. 9 comparisons, you will generate results that are So if you do enough statistical 10 statistically different. 11 am not a statistician, so I don't explain this very well. 12 I apologize. 13 Q. I am an epidemiologist, but I And I think you initially said that the study 14 was based upon proximity to coal ash impoundments in 15 North Carolina, whether or not they were near -- I think 16 you used the word -- "near" the facilities? 17 MR. HOLLEMAN: Object to the form. 18 THE WITNESS: The study was based on 19 proximity, current residents being somewhat near coal ash 20 impoundments. 21 22 BY MR. ROSSER: Q. Okay. When I look at the study, it appears 23 that the study was performed on a calendar basis; is that 24 correct? 25 A. That is correct. MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 158 And not necessarily proximity to a coal ash facility; is that right? 3 A. Yes, I think that is right. 4 Q. So when I look at this, the results -- and I 5 look at Table 1 on page 3 of 6, the bottom table there, 6 this refers to all cancers? 7 A. Uh-huh. 8 Q. And I see case -- the first column -- sorry. 9 The second column is -- refers to cases. Does that refer 10 to the number of all cancer cases within that county that 11 have been reported to the registry? 12 13 A. You are talking about Table 1, continued -- the bottom table on page 3 of 6? 14 Q. Just the bottom table. 15 A. Yeah. Yeah. Yeah, so that is all cases of cancer 16 reported in residents of that county to the cancer 17 registry during the time frame analyzed. 18 19 Q. And that time frame analyzed was from 2000 -- or, I am sorry, during 2009 to 2013? 20 A. That is correct. 21 Q. And then the next column says, "Rate." 22 23 What does that refer to? A. The rate is the number of cases in the first 24 column, over the average population for that county in 25 that time frame. And it is expressed -- I believe it is MEGAN MARIA DAVIES, M.D. 1 2 expressed per 100,000. Q. 5/4/16 PAGE 159 That is the usual convention. And if I am reading this table correctly, in 3 all but one of the counties -- that would be Rockingham 4 County -- with CCR impoundments in North Carolina, the 5 overall cancer rates were lower than the state rate; is 6 that correct? 7 MR. HOLLEMAN: Object to the form. 8 THE WITNESS: That is correct. 9 BY MR. ROSSER: 10 11 Q. If you go to page 2 of 6, on stomach cancer -- do you see that? 12 A. Yes. 13 Q. In all but three of the counties -- Caswell, 14 Person, and Cleveland -- with CCR impoundments in North 15 Carolina, rates for stomach cancer were lower than the 16 state rate. 17 Is that correct? (Witness peruses document.) 18 A. That is right. 19 Q. And then on page 3 of 6, for small intestine 20 cancer -- do you see that? 21 A. I do. 22 Q. In all but one of the counties with CCR 23 impoundments -- that being Gaston County -- rates for 24 small intestine cancer were lower than the state rate; is 25 that right? MEGAN MARIA DAVIES, M.D. 1 A. 5/4/16 PAGE 160 They are either lower or not calculated, 2 because that was, I think -- because the numerator was 3 too small. 4 5 MR. ROSSER: We will take five minutes. I am almost done. 6 MR. ROSSER: OFF THE RECORD. 2:15 P.M. 7 (A BRIEF RECESS WAS TAKEN.) 8 MR. ROSSER: ON THE RECORD. 9 MR. ROSSER: Dr. Davies, I have no further 2:18 A.M. 10 questions at this time. 11 though, is we have got a request outstanding to DEQ for 12 documents related to communications between DEQ and DHHS. 13 Those documents have not been made available as of yet. 14 So what I will request is that this deposition be held 15 open in case some of those documents for some -- for 16 whatever reason, compel us to try to bring you back here 17 for another session. 18 One thing that I do want to do, I doubt that will occur, but I just want to 19 leave open that possibility, in case we do discover 20 something in those documents that we want to talk to you 21 further about. 22 THE WITNESS: I understand. 23 MS. LeVEAUX: I don't have any questions. 24 MR. HOLLEMAN: Do you have any? 25 MR. ROBBINS: I have none. MEGAN MARIA DAVIES, M.D. 1 5/4/16 MR. HOLLEMAN: PAGE 161 I have some, following up on 2 the new exhibits he introduced. 3 30 minutes. 4 to go ahead and try to get through? And we have got ten minutes. 5 THE WITNESS: 6 2:45, but then I can't. 7 out of the building. 8 R E D I R E C T 9 10 It will probably take me Yeah. Do you want me I can -- I can go until Somebody will have to lead me E X A M I N A T I O N 2:19 P.M. BY MR. HOLLEMAN: Q. Duke's attorney gave you this study marked 11 Exhibit 296, the cancer study and asking -- answering 12 questions about it. 13 determining whether people who lived near coal ash 14 impoundments are getting a higher rate of cancer, this 15 study really is worthless as a scientific matter, 16 correct. And isn't it true that in terms of 17 MS. LeVEAUX: Objection to form. 18 THE WITNESS: It does not answer that 19 question. 20 21 BY MR. HOLLEMAN: Q. From this study, you can't tell one way or 22 another -- I mean, not you. One cannot tell, one way or 23 another, whether people who lived near Duke's coal ash 24 impoundments are getting a higher rate of cancer or not; 25 is that correct? MEGAN MARIA DAVIES, M.D. 1 A. 5/4/16 PAGE 162 Within the statistical limits of this study, 2 you can say whether people who live in a county with one 3 of these coal ash impoundments are --- 4 Q. Go ahead. I am sorry. 5 A. --- are getting a higher level of --- 6 Q. You can say what the people who live in the 7 county are, but not the people who live near the 8 impoundments; correct. 9 MR. ROSSER: 10 Object to the form. BY MR. HOLLEMAN: 11 Q. Within two miles of the coal ash sites? 12 A. Correct. 13 Q. And in addition, this doesn't -- this study 14 doesn't tell you anything about whether people who drink 15 the contaminated well water are getting a higher rate of 16 cancer; correct? 17 A. That is correct. 18 MR. ROSSER: 19 BY MR. HOLLEMAN: 20 Q. In fact, we saw earlier, Rowan County -- you 21 know that county? 22 right? 23 24 25 A. Object to the form. That is where Salisbury is located, I do know Rowan County. I do know Rowan County, yes. Q. That is where Buck is; correct? MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 163 1 A. Yes. 2 Q. And we saw that where some of the people who 3 live near the Duke coal ash impoundments have high levels 4 of hexavalent chromium in their well water, exceeding 5 one, five, ten, and even 20, the Town of Salisbury has 6 very low levels of hexavalent chromium, correct --- 7 MR. ROSSER: Object to the form. 8 MS. LeVEAUX: Objection. 9 MR. ROBBINS: Objection. 10 BY MR. HOLLEMAN: 11 Q. --- in their water? 12 A. Did I look at the Salisbury water? 13 Q. Yes, you did. 14 A. Then, yes. 15 Q. And so since the people who -- most of the 16 people -- the overwhelming majority of the people who 17 live in Salisbury are drinking water with low levels of 18 hexavalent chromium, it should come as no surprise that 19 the people who live in that county as a whole may not be 20 showing up with cancers traced to hexavalent chromium? 21 MS. LeVEAUX: Objection. 22 MR. ROSSER: Objection. 23 MR. ROBBINS: Objection. 24 THE WITNESS: I don't know what proportion 25 of people living in Salisbury drink public water versus MEGAN MARIA DAVIES, M.D. 1 PAGE 164 well water. 2 3 5/4/16 BY MR. HOLLEMAN: Q. No, I am talking about the well water right 4 around the Buck coal ash pond. 5 drink that. You do know how many It is less than 500? 6 A. Yes. 7 Q. Less than 200, perhaps -- or less than 500? 8 A. Yes. 9 MS. LeVEAUX: Objection. 10 THE WITNESS: Yes. 11 BY MR. HOLLEMAN: 12 Q. The whole county? 13 A. I don't know how many it is. 14 agreed to testing, but that number is known. 15 16 Not everybody BY MR. HOLLEMAN: Q. It in the hundreds? 17 MS. LeVEAUX: Objection. 18 MR. ROBBINS: Objection. 19 BY MR. HOLLEMAN: 20 Q. Would that be true? 21 A. I -- I just don't know. 22 Q. But you do know it is a small portion of the 23 I --- population of Rowan County? 24 THE WITNESS: Yes. 25 MS. LeVEAUX: Objection. MEGAN MARIA DAVIES, M.D. 1 PAGE 165 BY MR. HOLLEMAN: 2 3 5/4/16 Q. Now, Duke's lawyer showed you this Exhibit 293, which is "chromium-6 in U.S. Tap Water." 4 A. What was the number? 5 Q. 293. 6 A. Yes. 7 Q. I believe you said you had never seen that 8 before; is that correct? 9 A. That is correct. 10 Q. So as far as you remember, it wasn't in the 11 DHHS -- at least it wasn't part of the materials you saw 12 at HHS related to chromium? 13 A. Correct. 14 Q. If you could then look at those "Frequently 15 Asked Questions," Exhibit 286. 16 A. Yes. 17 Q. Now, do you know who prepared these 18 "Frequently Asked Questions"? 19 A. Department of Environmental Quality. 20 Q. Who? 21 A. The Department of Environmental Quality. 22 Q. Did you or DHHS have any role in it that you 23 remember? 24 25 A. them. We were sent copies to look at and comment on MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 166 Do you remember if you reviewed it and commented on it? 3 A. If I reviewed it and commented on it? 4 is hard to hear you, too. 5 don't know if I reviewed it before it went up on the 6 website. 7 Q. Did you submit any comments to DEQ about it? 8 A. Yes. 9 I did review it. See, it I don't -- I And, actually, I am remembering that this came to me for review with a very short turnaround 10 time before it was posted. 11 something, somewhere, and trying to review it on my 12 i-Phone, or whatever kind of device I had at the time -- 13 SmartPhone. 14 I was driving back from So I had some comments. I don't know if they 15 -- I can't recall the timing of -- or -- I actually don't 16 remember what the comments were anymore. 17 18 Q. I was going to ask you, you do not remember the substance of your comments? 19 A. I don't. 20 Q. Did you submit them in writing or orally? 21 A. I might have sent an e-mail with comments in 22 it. I spoke by phone with the communications staff at 23 Department of Health and Human Services. 24 Q. Do you remember who you spoke to? 25 A. I think it was Alex Lefebvre. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 167 1 Q. Do you know who you sent the e-mail to? 2 A. I am not sure I sent an e-mail, so, no. 3 Q. No? Okay. Well, look at -- if you could, 4 look at page 4 of the "Frequently Asked Questions." This 5 is the chart that Duke's lawyer asked you about. 6 And then look at page 10 of the report Duke's lawyer 7 provided you. 8 of the report that Duke's lawyer provided you, you will 9 see the four highest cities in America on that chart for Okay. And if you look at that chart, on page 10 10 hexavalent chromium are Norman, Oklahoma; Honolulu, 11 Hawaii; Riverside, California; and Madison, Wisconsin. 12 Do you see that? 13 A. Yes. 14 Q. And do you see those very cities somehow found 15 their way into this chart in this "Frequently Asked 16 Questions" provided to the public? 17 A. Yes. 18 MR. ROSSER: 19 BY MR. HOLLEMAN: 20 21 Q. What is your question? And those are the cities, are they not, that show some of the very high numbers? 22 MR. ROSSER: Object to form. 23 THE WITNESS: Yes. 24 BY MR. HOLLEMAN: 25 Q. Now, in fact, of course, people in North MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 168 1 Carolina don't drink water from Honolulu, Hawaii, do 2 they, as a regular matter; correct? 3 A. Yes. 4 Q. So if you look just at the North Carolina 5 cities in this chart, and not the cities pulled out of 6 this report, the North Carolina numbers for hexavalent 7 chromium are much lower; are they not? 8 9 10 A. Are you talking about the "Frequently Asked Questions" Table? Q. Yeah -- yes, ma'am, on four. In other words, 11 Charlotte, Greensboro, and Raleigh -- and they only put 12 in three cities in North Carolina -- but they are all -- 13 they all had much lower levels of hexavalent chromium; do 14 they not? 15 A. Lower than? 16 Q. Well, for example, Norman, Oklahoma, which for 17 18 19 20 some reason was picked out for this chart? A. The North Carolina cities' highest levels are much lower than the Normal, Oklahoma highest levels. Q. And in fact, their lowest level in the 21 range -- the bottom end of the range for all three North 22 Carolina cities are below the health screening level, are 23 they not? 24 A. Yes. 25 Q. And when this chart was put together, instead MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 169 1 of giving the mean or average amount of chromium-6 level, 2 they put in a range that would include the highest 3 measurement obtained, did they not? 4 MR. ROSSER: Object to the form. 5 MS. LeVEAUX: Objection. 6 MR. ROBBINS: Objection. 7 THE WITNESS: It would appear so. 8 BY MR. HOLLEMAN: 9 Q. And if you look again at this chart -- the 10 chart in the report that Duke's lawyer gave you, at page 11 10, you see some very well known cities -- New York, New 12 York, Miami, Florida, Boston, Massachusetts, Cincinnati, 13 Ohio, and Indianapolis, Indiana -- all have hexavalent 14 chromium levels below your health screen level; isn't 15 that correct. 16 MR. ROSSER: Object to the form. 17 THE WITNESS: They have lower levels on this 18 chart. 19 BY MR. HOLLEMAN: 20 Q. But none of those well-known cities made it 21 into the DEQ "Frequently Asked Questions" chart, did 22 they? 23 MS. LeVEAUX: Objection. 24 THE WITNESS: They are not on the Frequently 25 Asked Question chart. MEGAN MARIA DAVIES, M.D. 1 2 5/4/16 PAGE 170 BY MR. HOLLEMAN: Q. Did you ever have any discussions with anyone 3 at DEQ or elsewhere about why these particular places, 4 such as Norman, Oklahoma, were picked out to be put into 5 this chart for North Carolina residents to review about 6 their risk from hexavalent chromium? 7 A. No. 8 MS. LeVEAUX: 9 BY MR. HOLLEMAN: 10 Q. Objection. Now, if you look, also, at the same frequently 11 asked questions -- I am sorry, not that. 12 to something else. 13 Exhibit 291, the April 2016 report --- Let me go back If you could look at this report, 14 A. Yes. 15 Q. --- now, did you or others at HHS work in 16 conjunction with DEQ to produce this report? 17 A. No. 18 Q. Did they ever meet with you about this report 19 before it was written? 20 A. Not that I am aware of. 21 Q. Did they ask -- I believe you said earlier you 22 provided them days where you would meet with them; is 23 that correct? 24 A. That is not correct. 25 Q. Okay. Correct me on that. MEGAN MARIA DAVIES, M.D. 1 2 A. 5/4/16 PAGE 171 I didn't provide dates, but I said we were available for staff meetings. 3 Q. And you never heard anything back from DEQ? 4 MS. LeVEAUX: Objection. 5 THE WITNESS: I don't remember any. 6 BY MR. HOLLEMAN: 7 8 Q. Did they ever ask you for information to put into this report before it was submitted? 9 MS. LeVEAUX: Objection. 10 THE WITNESS: I don't think so. 11 BY MR. HOLLEMAN: 12 Q. And before the report was issued, did you or 13 HHS play any role in coming up with the recommendations 14 that are in the report? 15 MS. LeVEAUX: Objection. 16 THE WITNESS: I don't know. 17 BY MR. HOLLEMAN: 18 Q. But you did not? 19 A. I did not. 20 A. Now, I notice this report never says that HHS 21 didn't participate in its preparation. 22 that? 23 24 25 A. HHS reviewed it before it was submitted to the General Assembly. Q. Did you notice So in that sense, we participated. So you reviewed it, but you didn't participate MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 172 in putting together the recommendations --- 2 MS. LeVEAUX: Objection. 3 MR. ROSSER: Objection. 4 BY MR. HOLLEMAN: 5 Q. --- is that correct? 6 A. I don't know if anyone else in HHS did. 7 Q. Did you raise an issue, or did anyone else at 8 HHS raise an issue about whether this report should note 9 the very limited role that HHS played in connection --- 10 MS. LeVEAUX: Objection. 11 MR. ROSSER: Objection to form. 12 THE WITNESS: I did not raise that issue. 13 BY MR. HOLLEMAN: 14 Q. Do you know if someone else did? 15 A. I don't know if someone else did. 16 Q. If you could look at page 4 of that report, 17 it says that DEQ recommends that HHS include additional 18 information that the EPA current limit for, they say, 19 hexavalent chromium is 100 parts per billion; do you see 20 that? 21 MS. LeVEAUX: Objection. 22 THE WITNESS: Is this the third 23 paragraph --- 24 25 BY MR. HOLLEMAN: Q. (Interposing) Yes, ma'am. MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 173 1 A. --- on page 4? 2 Q. Yes, ma'am. 3 A. “DEQ recommends that DHHS include additional 4 clarifying information in the issuance of HREs that 5 explains that both bottled water, regulated by the U.S. 6 Food and Drug Administration, and water supply by Public 7 Water Supply regulated by the U.S. EPA, may potentially 8 and legally contain up to 100 micrograms of hexavalent 9 chromium measured as total chromium.” 10 Q. Yes, I see that. Now, this report does not recommend that the 11 consumers of this water -- the public -- be informed, 12 that EPA was reviewing that standard, does it? 13 MS. LeVEAUX: Objection. 14 THE WITNESS: I don't see that in here. 15 BY MR. HOLLEMAN: 16 Q. And nor does it recommend that the public be 17 informed that EPA came up with this standard before they 18 were aware that hexavalent chromium was a human 19 carcinogen? 20 MR. ROSSER: Objection to form. 21 MR. ROBBINS: Objection. 22 THE WITNESS: That is not in there. 23 BY MR. HOLLEMAN: 24 25 Q. All right. And do you know that it is true that EPA came up with the chromium -- total chromium MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 174 1 standard of 100 before it was known that hexavalent 2 chromium was a human carcinogen? 3 A. That sounds familiar, but I don't know that. 4 Q. Now, did you -- they say at the end, here, 5 that "by providing the information -- only the 6 information they suggest, that will allow for a more 7 informed health risk conclusion by the private well 8 owner." Do you agree with that statement? 9 A. Yes. 10 Q. Do you think it would be -- the private well 11 owner would have more important information if he or she 12 were told about the limitations on the EPA 100 parts per 13 billion standard? 14 MS. LeVEAUX: Objection. 15 THE WITNESS: I think that if you are 16 providing additional information to contextualize the 17 homeowners' decision -- decision process for managing 18 their risk, we should provide full additional 19 information. 20 21 22 23 BY MR. HOLLEMAN: Q. And that would include the explanations concerning the limitations on the EPA limit? A. Yes. 24 MR. ROSSER: Objection to form. 25 MR. ROBBINS: Objection. MEGAN MARIA DAVIES, M.D. 1 PAGE 175 BY MR. HOLLEMAN: 2 3 5/4/16 Q. Now, are you aware that vanadium is considered to be a possible human carcinogen? 4 A. No. 5 Q. Just to clear this up, when you are doing 6 research on the cancer-causing effects substances in 7 humans, it is a recognized practice in science to do 8 animal tests; is that correct? 9 A. Yes. 10 Q. And some of those tests are done on mice; is 11 that correct? 12 A. Yes. 13 Q. And it is considered ethically prohibited to 14 do tests on cancer-causing substances on human beings; is 15 that correct? 16 A. Yes. 17 Q. Now, you are aware Mr. Reeder criticized the 18 existing science on hexavalent chromium by pointing out 19 that it was based on tests on mice? 20 saying that? Do you remember him 21 MR. ROSSER: Objection to form. 22 MR. ROBBINS: Objection. 23 THE WITNESS: I don't remember him saying 24 25 that. BY MR. HOLLEMAN: MEGAN MARIA DAVIES, M.D. 1 2 Q. 5/4/16 PAGE 176 Do you remember him saying something like that at the legislative hearing that you attended? 3 MS. LeVEAUX: Objection. 4 MR. ROSSER: Same objection. 5 MR. ROBBINS: Objection. 6 THE WITNESS: I don't remember that part. 7 BY MR. HOLLEMAN: 8 9 Q. Are you aware there are also so-called correlational studies of human populations that are 10 sometimes done to see if there is an association between 11 a substance and human cancers? 12 A. Yes. 13 Q. And are you aware that has been done with 14 15 16 17 respect to hexavalent chromium in a community in Greece? A. chromium. Q. I am aware it has been done with hexavalent I didn't recollect Greece. And are you aware that those correlational 18 human studies have shown a correlation between hexavalent 19 chromium and human cancers? 20 MR. ROSSER: Object to the form. 21 THE WITNESS: I am aware that there are 22 epidemiological studies that show a correlation between 23 exposure to hexavalent chromium and human cancer. 24 25 BY MR. HOLLEMAN: Q. If you look at page -- again, back to the MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 177 1 report, 291 -- that is not what I wanted to direct you 2 to. 3 that, Duke's attorney asked you some questions. 4 just want to ask you a couple related to those. If I could direct you to 294, and at the very end of And I 5 A. Okay. 6 Q. He asked you about this phrase where the DHH 7 spokeswoman said that it was not one person who decided 8 to update recommendations. Do you see that phrase? 9 A. Yes. 10 Q. Now, was there more than one person in HHS who 11 decided to update the recommendations? Other than 12 Dr. Williams, was anyone else in HHS in favor of issuing 13 the "Do Drink" letter? 14 A. I am not sure. 15 Q. But you don't know of anyone? 16 A. I don't -- don't know absolutely. 17 Q. So the other people were in DEQ; is that 18 correct? 19 MS. LeVEAUX: Objection. 20 THE WITNESS: I don't know. 21 BY MR. HOLLEMAN: 22 Q. Well, I think -- I believe you said to Duke's 23 attorney that it was correct that more than one person 24 decided to update the recommendation. 25 other person, other than Dr. Williams -- or was it only So who was the MEGAN MARIA DAVIES, M.D. 1 PAGE 178 Dr. Williams? 2 3 5/4/16 A. So I might -- I might need to correct what I said to the Duke attorney, in that I don't know. 4 Q. Of anyone other than Dr. Williams? 5 A. That is correct. 6 Q. Duke's attorney asked you if bottled water was 7 regulated under the Safe Drinking -- federal Safe 8 Drinking Water Act. 9 no; is that correct? And I believe you said, in general, 10 A. Yes. 11 Q. However, if municipal -- water from a 12 municipal system was used to fill the bottled water 13 containers, then, in effect, the water contained in the 14 bottle -- the bottles would be -- have been regulated by 15 the Safe Drinking Water Act; is that correct? 16 MS. LeVEAUX: Objection. 17 MR. ROSSER: Objection. 18 MR. ROBBINS: Objection. 19 THE WITNESS: I don't know enough about 20 either the legal or the manufacturing process to answer 21 that. 22 23 BY MR. HOLLEMAN: Q. Now, you said you -- he asked you if anybody 24 regulates it. And you said you weren't sure, that it 25 might be regulated by the Food and Drug Administration; MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 179 is that correct? 2 A. Yes. 3 Q. And by "it," I mean bottled water. 4 A. Yes. 5 6 I am pretty sure it is regulated by the Food and Drug Administration. Q. Now, he asked you about different levels of 7 carcinogen. 8 carcinogen is without risk to the human? 9 every level of the human carcinogen has some risk if 10 11 Isn't it true that no level of a human In other words, ingested by a human; is that true? A. What I have -- what I understand from 12 briefings from the toxicologist at Occupational and 13 Environmental Epidemiology Branch, and from lectures I 14 have attended, is that mutagenic carcinogens are not 15 presumed to be safe at any -- not presumed to be without 16 risk at any level. 17 18 Q. And hexavalent chromium is mutagenic carcinogen; is that correct? 19 A. Yes. 20 Q. The standard you used is the one in a million 21 standard, which is the standard generally accepted in the 22 field of toxicology and epidemiology; is that correct? 23 MR. ROSSER: Objection. 24 THE WITNESS: It is the standard laid out in 25 the 2L Rule. And it is a generally accepted standard in MEGAN MARIA DAVIES, M.D. 1 PAGE 180 the field of health risk evaluation. 2 3 5/4/16 BY MR. HOLLEMAN: Q. Now, there is also the possibility or -- not 4 just possibility, recognized fact, that different 5 carcinogens and different substances can interact with 6 each other and cause what sometimes is referred to as a 7 synergistic effect: that is, to make each of them more 8 dangerous than they would be alone; is that right? 9 A. Yes. 10 Q. And this one in a million standard, is that 11 one of the reasons why we have a one in a million 12 standard, because your risk or someone else's risk from 13 ingesting this may be much higher? 14 MS. LeVEAUX: Objection. 15 MR. ROSSER: Objection. 16 MR. ROBBINS: Objection. 17 THE WITNESS: My understanding of health 18 risk evaluation principles -- and it has been established 19 that I am not an expert in health risk evaluation -- my 20 understanding of those principles is that there are 21 uncertainty factors included in all the calculations to 22 account for that kind of variation. 23 24 25 BY MR. HOLLEMAN: Q. Now, if I could take you back to those "Frequently Asked Questions" Duke's attorney asked you MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 181 1 about, Exhibit 286, and look at page 2, and it recites 2 that HHS used the one in one million standard; correct? 3 A. Where is that on the page? 4 Q. Under "What does it mean if HER or HHS suggest 5 I do not drink the water?” 6 A. Yes. 7 Q. Okay. Now, this question as written addresses 8 the people who have actually received the HRE; is that 9 correct -- what you were reading? 10 A. Yes. 11 Q. Now, many of these people -- and you have seen 12 some examples -- had hexavalent chromium in their 13 drinking water at many multiples of one in a million risk 14 level; isn't that correct? 15 MS. LeVEAUX: Objection. 16 MR. ROSSER: Objection. 17 THE WITNESS: There were results that are 18 associated with a risk of more than on order of magnitude 19 of one in a million. 20 21 BY MR. HOLLEMAN: Q. So in other words, one in a million is .07. 22 And we have seen -- you have two before you that are 23 around 21 parts per billion? 24 A. Yes. 25 Q. And that is a one in -- roughly one in 3,000 MEGAN MARIA DAVIES, M.D. 1 5/4/16 PAGE 182 risk? 2 A. So I just do it by order of magnitude. 3 Q. Sure. 4 A. So, yes, that is the correct order of 5 magnitude. 6 Q. 7 8 But there is nothing --MR. ROSSER: Sorry. (Interposing) Excuse me. We are at 2:49 now. 9 MR. HOLLEMAN: You have to run? 10 THE WITNESS: I do. 11 MR. HOLLEMAN: Can I ask you one more THE WITNESS: Can I ask it walking out the MR. ROSSER: She has got to go. 12 question? 13 14 15 16 17 18 door? We said 2:30 originally. MR. HOLLEMAN: Okay. Thank you. Well, let me review my material and see if I need to come back. 19 THE WITNESS: Thank you all. 20 (THE DEPOSITION WAS ADJOURNED AT 2:49 P.M. 21 TO RECONVENE AT AN UNSPECIFIED LATER TIME AND 22 DATE.) MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 183 S I G N A T U R E I HAVE READ THE FOREGOING PAGES * TO *** WHICH CONTAIN A CORRECT TRANSCRIPT OF THE ANSWERS MADE TO THE QUESTIONS HEREIN RECORDED. MY SIGNATURE IS SUBJECT TO CORRECTIONS ON ATTACHED ERRATA SHEET, IF ANY. ______________________________________________ (SIGNATURE OF MEGAN MARIA DAVIES, M.D.) STATE OF COUNTY OF I CERTIFY THAT THE FOLLOWING PERSON PERSONALLY APPEARED BEFORE ME THIS DAY, AND I HAVE PERSONAL KNOWLEDGE OF THE IDENTITY OF THE PRINCIPAL OR HAVE SEEN SATISFACTORY EVIDENCE OF THE PRINCIPAL’S IDENTITY, OR A CREDIBLE WITNESS KNOWN TO ME HAS SWORN TO THE IDENTITY OF THE PRINCIPAL, ACKNOWLEDGING TO ME THAT HE OR SHE VOLUNTARILY SIGNED THE FOREGOING DOCUMENT FOR THE PURPOSE STATED HEREIN AND IN THE CAPACITY INDICATED: _______________________________ (NAME OF PRINCIPAL) _______________________________________ (DATE) _______________________________________ (SIGNATURE OF NOTARY) (OFFICIAL SEAL) _______________________________________ (NOTARY’S PRINTED NAME) ******************************************************************* I, MICHAEL B. CARTER, NOTARY/REPORTER, DO CERTIFY THAT THE FOREGOING TRANSCRIPT WAS DELIVERED TO THE WITNESS EITHER DIRECTLY OR THROUGH THE WITNESS’ ATTORNEY OR THROUGH THE ATTORNEY RETAINING THE WITNESS ON ______________________, AND THAT AS OF THIS DATE, I HAVE NOT RECEIVED THE EXECUTED SIGNATURE PAGE OR ERRATA SHEET. THEREFORE, MORE THAN 30 DAYS HAVING ELAPSED SINCE THE RECEIPT OF THE TRANSCRIPT BY THE WITNESS, THE SEALED ORIGINAL TRANSCRIPT IS HEREBY FILED WITH THE ORDERING ATTORNEY BY MEANS OF PRIORITY MAIL IN ACCORDANCE WITH THE NORTH CAROLINA RULES OF CIVIL PROCEDURE. _________________________ (DATE) ______________________________ MICHAEL B. CARTER, NOTARY/REPORTER NOTARY NUMBER 19960030065 MY COMMISSION EXPIRES FEBRUARY 15, 2021 MEGAN MARIA DAVIES, M.D. 5/4/16 PAGE 184 STATE OF NORTH CAROLINA COUNTY OF NASH C E R T I F I C A T E I, MICHAEL B. CARTER, NOTARY PUBLIC-REPORTER, DO HEREBY CERTIFY THAT MEGAN MARIA DAVIES, M.D. WAS DULY SWORN BY ME PRIOR TO THE TAKING OF THE FOREGOING DEPOSITION, THAT THE IDENTITY OF THE WITNESS WAS VERIFIED, THAT SAID DEPOSITION WAS TAKEN BY ME AND TRANSCRIBED UNDER MY DIRECTION, AND THAT THE FOREGOING 183 PAGES CONSTITUTE A TRUE AND CORRECT TRANSCRIPT OF THE TESTIMONY OF THE WITNESS. I DO FURTHER CERTIFY THAT I AM NOT COUNSEL FOR OR IN THE EMPLOYMENT OF ANY OF THE PARTIES TO THIS ACTION, NOR AM I INTERESTED IN THE RESULTS OF THIS ACTION. I DO FURTHER CERTIFY THAT THE STIPULATIONS CONTAINED HEREIN WERE ENTERED INTO BY COUNSEL IN MY PRESENCE. IN WITNESS WHEREOF, I HAVE HEREUNTO SET MY HAND THIS 8TH DAY OF MAY, 2016. MICHAEL B. CARTER NOTARY PUBLIC FOR THE STATE OF NORTH CAROLINA NOTARY NUMBER 19960030065 MY COMMISSION EXPIRES FEBRUARY 15, 2021